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ABSTRACT 
Radiocontrast media (RCM) are necessary for many diagnostic procedures such as arteriography, 
percutaneous coronary intervention (PCI), and computed tomography. Contrast-induced acute 
kidney injury (CI-AKI) is the third most common cause of hospital-associated kidney damage 
accounting for 10-25% of cases worldwide. The mechanisms of contrast-induced renal 
impairment are not entirely known, but diminished renal hemodynamics, inflammatory 
responses, and direct cytotoxicity have been hypothesized. The purpose of this study was to 
investigate the mechanisms of direct cytotoxicity observed in HK-2 cells following treatment 
with diatrizoic acid (DA) and to determine the source of this damage. Mitochondrial function, 
endoplasmic reticulum (ER) stress, oxidative stress, and the role of calcium were examined in 
response to exposure to DA. HK-2 cells were grown to confluency for 48 hr and exposed to 0-30 
mg I/mL of DA for 2, 8, or 24 hr. The vehicle used for all studies was phosphate buffered saline 
(PBS). Mitochondrial and cell viability were decreased within 2 and 24 hr, respectively, as 
shown by MTT assays and trypan blue exclusion cell counts. Mitochondrial function was 
monitored using an Agilent Seahorse analyzer and cell mito stress tests, cell glycolysis stress 
tests, mito fuel flex tests, and real-time ATP rate assays. Oxidative stress, ER stress, and 
mitophagy were assessed in whole cell lysate and cell fractions using OxyBlot and Western blot 
analysis for 4-hydroxynonenol (4-HNE), tumor necrosis factor alpha (TNFα), NADPH oxidase 4 
(NOX4), manganese superoxide dismutase (MnSOD), glucose-regulated protein 78 (GRP78), 
C/EBP homologous protein (CHOP), microtubule-associated proteins 1A/1B light chain 3B 
(LC3B), cytochrome c, and caspases 3, 4, and 12. The role of calcium in mitophagy and 
apoptosis was determined by pretreating HK-2 cells with various calcium modulators such as 
BAPTA-AM, EGTA, 2-APB,  or calpeptin prior to the addition of DA. Studies conducted using 
xiv 
 
Seahorse XF technology and analysis of LC3BI and II expression determined that DA alters 
mitochondrial function within 8 hr. MTT and calpain activity assays indicated that disruption of 
calcium homeostasis plays a role in DA induced cytotoxicity within 8 hr. An increase in 
oxidative stress and loss of mitochondrial membrane integrity was evident within 24 hr exposure 
to 18 mg I/mL DA. DA induces apoptosis at 24 hr exposure as shown by Western blot analysis 
of cytochrome c leakage and activation of caspase 3 and 12. These studies indicate that 
mitochondrial damage and oxidative stress occur in HK-2 cells treated with DA, and maintaining 
calcium homeostasis may help prevent DA-induced cytotoxicity. 
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ABSTRACT 
The administration of intravenous iodinated radiocontrast media (RCM) to visualize 
internal structures during diagnostic procedures has increased exponentially since their first use 
in 1928. A serious side effect of RCM exposure is contrast-induced acute kidney injury (CI-
AKI), which is defined as an abrupt and prolonged decline in renal function occurring 48–72 
hours after injection. Multiple attempts have been made to decrease the toxicity of RCM by 
altering ionic strength and osmolarity, yet there is little evidence to substantiate that a specific 
RCM is superior in avoiding CI-AKI. RCM-associated kidney dysfunction is largely attributed to 
alterations in renal hemodynamics, specifically renal vasoconstriction; however, numerous 
studies indicate direct cytotoxicity as a source of epithelial damage. Exposure of in vitro renal 
proximal tubule cells to RCM has been shown to affect proximal tubule epithelium in the 
following manner: 1) changes to cellular morphology in the form of vacuolization; 2) increased 
production of reactive oxygen species, resulting in oxidative stress; 3) mitochondrial 
dysfunction, resulting in decreased efficiency of the electron transport chain and ATP 
production; 4) perturbation of the protein folding capacity of the endoplasmic reticulum (ER) 
(activating the unfolded protein response and inducing ER stress); and 5) decreased activity of 
cell survival kinases. The present review focuses on the direct cytotoxicity of RCM on proximal 
tubule cells in the absence of in vivo complications, such as alterations in renal hemodynamics or 
cytokine influence. 
INTRODUCTION 
Administration of radiocontrast media (RCM) necessary for X-ray based imaging 
procedures such as percutaneous coronary intervention and cardiac angiography may lead to 
contrast-induced acute kidney injury (CI-AKI). The severity of this dysfunction can range from 
3 
non-symptomatic increases in serum creatinine (SCr) to severe and permanent renal damage 
resulting in the need for dialysis (Brown et al., 2016). CI-AKI is defined as an absolute increase 
in SCr greater than 0.5 mg/dl or a relative increase of greater than 25% of baseline SCr peaking 
3-5 days after administration and returning to baseline within 10-14 days in the absence of other 
contributing factors (Mehran & Nikolsky, 2006; Thomsen & Morcos, 2003). Currently, the exact 
mechanisms of RCM nephrotoxicity have not been fully elucidated; however, hypothesized 
sources include alterations in renal hemodynamics and direct toxicity to renal epithelium 
mutually resulting in an increase in reactive oxygen species (ROS) and oxidative damage. Renal 
ischemia is a complex result of severe renal vasoconstriction, decreased oxygen supply, and 
increased oxygen demand within the renal outer medulla (J. S. Yang et al., 2018). Although a 
vast number of clinical reports and observational studies have explored the incidence of CI-AKI 
following administration of RCM, most finding significant risk, little is known about the direct 
cellular toxicity induced by RCM. To determine the source of RCM induced cytotoxicity, in 
vitro models must be implemented to eliminate renal hemodynamic and inflammatory responses 
to RCM administration. This minireview briefly discusses the characterization of RCM, renal 
pathogenesis, and risk factors involved in CI-AKI, as well as the direct toxic effects of RCM on 
cellular antioxidant systems, mitochondria, the endoplasmic reticulum (ER) and the unfolded 
protein response (UPR), and activity of stress kinases in in vitro systems. This short review also 
briefly addresses current and experimental preventative measures for CI-AKI.  
RADIOCONTRAST MEDIA 
The first RCM developed for intravenous administration, uroselectan, diodrast and 
hippuran, were synthesized in the late 1920s for use in urography procedures (Swick, 1930). 
During this time, advances to understand the relationships between chemical structure, toxicity, 
4 
and pharmacokinetics were being made, resulting in the discovery of the parent compound to all 
modern RCM, acetrizoic acid (Wallingford, 1953). Continuation of these developments led to 
the detection of RCM that are much more tolerable and increasingly radiopaque compared to 
early radiopaque compounds.  
The first generation of modern RCM are derivatives of acetrizoic acid, ionic monomers, 
and have osmolalities 5-8 fold greater than plasma, thus were denoted high-osmolar contrast 
media (HOCM). The ionization of early RCM have been associated with many toxic reactions 
including: severe nephrotoxicity (Schreiner, 1966; Stokes & Bernard, 1961), induction of 
convulsions and seizures (Melartin, Tuohimaa, & Dabb, 1970), pancreatitis in patients 
undergoing endoscopic retrograde cholangio-pancreatography (Banerjee, Grainger, & 
Thompson, 1990), severe and potentially fatal thrombi in patients with sickle-cell anemia 
(McNair, 1972), inhibition of platelet aggregation in vivo and in vitro (Gafter et al., 1979), and 
blood volume expansion leading to right heart volume overload in patients with poor cardiac 
function (Widmark, 2007). The theory that first generation RCM ionicity and osmolality were 
critical contributors to toxicity led to the dimerization or replacement of carboxyl groups with 
non-dissociating hydrophilic groups (Stratta, Quaglia, Airoldi, & Aime, 2012). The resulting 
generation of RCM consisted of ionic dimers and non-ionic monomers that had osmolalities 2-3 
fold greater than plasma and were labeled low-osmolar contrast media (LOCM). The practice of 
decreasing RCM osmolality continued resulting in the third generation of RCM of non-ionic-
dimers that exhibit osmolality that is equivalent to plasma and are designated iso-osmolar 
contrast media (IOCM). 
Following intravenous administration, RCM are rapidly diluted and distributed by 
circulating plasma reaching concentrations adequate for visualization in approximately 5-10 
5 
minutes. First generation RCM have a low serum-albumin binding of 0-10% while second and 
third generation RCM show no notable serum protein binding. RCM of all generations show no 
significant metabolism and are excreted unchanged predominately through the kidneys by 
glomerular filtration with a very small percentage, less than 2%, recovered in the feces 
(Amersham-Health, 2007; GE-Healthcare, 2006). The pharmacokinetics of RCM can be 
described by a two-compartment model consisting of a rapid distribution alpha phase and a slow 
excretion beta phase. In patients with normal kidney function, the alpha phase and beta phase 
half-lives for diatrizoic acid are 30 minutes and 120 minutes, respectively. However, in patients 
with significant renal impairment, the beta phase half-life can be prolonged for several days 
(Amersham-Health, 2007). 
The indications for RCM change in accordance to procedure and risk of the patient 
involved. All generations of RCM are used for angiocardiography, although the use of HOCM is 
not recommended in patients with renal or cardiac insufficiencies. HOCM are used specifically 
for nonvascular procedures such as pyelography, cystography, and routine computed tomography 
procedures. LOCM and IOCM are used for vascular procedures and multi-detector computed 
tomography (Radiology, 2018). It is commonly accepted that a major portion of the toxicity of 
RCM is due to elevated osmolalities, however, reducing the osmolality of RCM results in a 
substantial increase in RCM viscosity (Figure 1). High injection rates of RCM with higher 
viscosities could be a contributing factor in stasis of renal tubular function (Ueda, Nygren, 
Hansell, & Ulfendahl, 1993). Although there is considerable dissension as to which generation of 
RCM is the safest, IOCM are thought to be optimal as they deliver the most iodine per molecule 
with the least impact on osmolality. Figure 2 describes the physical structures of various RCM. 
Table 1 summarizes several parameters of the various generations of RCM.  
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Figure 1. Relationship between osmolality and viscosity for RCM agents. Maximum 
concentrations of iodine provided by the manufactures and corresponding viscosities at 37°C. 
Refer to Table 1 for values.  
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Figure 2. Molecular structures of different RCM. Parent compound to modern RCM, 
acetrizoic acid (A), first generation ionic monomer, diatrizoic acid (B), second generation non-
ionic monomer, Iohexol (C) and ionic dimer, ioxaglate (D), and third generation non-ionic 
dimer, iodixanol (E). 
 
RENAL PATHOGENESIS  
The administration of intravenous iodinated RCM for diagnostic procedures and medical 
interventions have increased exponentially since their introduction in the late 1920s. 
Unfortunately, CI-AKI is the third most common cause of hospital-acquired kidney damage, 
accounting for 12% of cases (Gleeson & Bulugahapitiya, 2004; Nash, Hafeez, & Hou, 2002). 
The level of this dysfunction can vary from a mild increase in SCr to permanent renal failure 
resulting in dialysis (Brown et al., 2016). Although the definition of CI-AKI varies in the 
8 
literature, it is generally defined as an absolute increase in SCr greater than 0.5 mg/dl or a 
relative increase of greater than 25% of baseline SCr peaking 3-5 days after administration and 
returning to baseline within 10-14 days (Mehran & Nikolsky, 2006; Thomsen & Morcos, 2003). 
The incidence of CI-AKI is low, less than 2%, in patients with normal to slightly diminished 
renal function (GFR > 60 ml/min per 1.73 m2) (Berns, 1989; Weisbord & Palevsky, 2008); 
however, in high-risk patients with moderate to severe renal impairment the incidence is as high 
as 55% (Mehran & Nikolsky, 2006).  
 
Table 1. Summary of various parameters of RCM. (Radiology, 2018) 
 
Although the exact mechanisms of toxicity of RCM have not been fully elucidated, it is 
hypothesized that the acute deterioration of kidney function is caused by a combination of renal 
medullary hypoxia and direct toxicity to renal epithelial cells. Intravenous administration of 
RCM induces transient vasodilation of renal vasculature followed by severe, sustained 
vasoconstriction, specifically of the afferent arterioles, resulting in decreased oxygen supply and 
oxidative damage to the outer medulla (Z. Z. Liu et al., 2012; Persson, Hansell, & Liss, 2005). 
This response is likely due to modifications of endogenous renal vasomodulators, specifically 
nitric oxide (NO), endothelin, and adenosine (Hall et al., 1992). The production of the 
9 
vasodilator NO decreases in response to RCM resulting in exacerbation of renal vasoconstriction 
(Touati et al., 1993). Levels of endothelin, a vasoconstrictive peptide released by endothelial 
cells to maintain blood pressure, have been shown to increase after RCM exposure (Clark, Kim, 
& Epstein, 1997). It is also apparent that adenosine plays a role in inducing CI-AKI. Intrarenally 
administered adenosine produces biphasic hemodynamic alterations that are similar to those 
induced by RCM (Arend et al., 1987).  
The oxidative damage induced by vasoconstriction is compounded in the relatively 
hypoxic renal medullae. Under normal physiological function, the medulla functions at very low 
O2 tension as the result of limited blood flow and the ‘oxygen shunt’ caused by the anatomy of 
the outer medullary vasculature (Heyman, Rosen, & Brezis, 1997; Leong, Anderson, O'Connor, 
& Evans, 2007). Along with poor O2 delivery, O2 consumption within the outer medullae is high 
due to ion reabsorption by the thick ascending limb (TAL) of the nephron (Heyman et al., 1997). 
The combined effects of low O2 delivery and high O2 consumption renders the renal medullae 
particularly susceptible to hypoxic injury. RCM exposure has been shown to further decrease O2 
tension within the renal medulla and simultaneously induce osmotic diuresis and increase ion 
transport and O2 consumption at the TAL (Cronin, 2010; Heyman et al., 1991). Additionally, an 
increase in tubular pressure secondary to RCM induced diuresis, increased urinary viscosity, and 
tubular obstruction result in increased oxygen consumption, worsening ischemic damage 
(Gleeson & Bulugahapitiya, 2004). The combination of alterations in vasomodulators and 
increased oxidative damage may exert direct tubular and vascular endothelial damage leading to 
a vicious cycle of hypoxic damage in the renal parenchyma (Heyman et al., 2010). Although 
renal papillary necrosis is not a hallmark of CI-AKI, administration of RCM is contraindicated in 
patients that are undergoing selective or nonselective nonsteroidal anti-inflammatory drug 
10 
(NSAID) therapy. Concomitant use may aggravate NSAID induced renal vasoconstriction, 
therefore, NSAID therapy should be suspended 48 hours prior to RCM administration (Horl, 
2010). 
RISK FACTORS  
Prevention and treatment of CI-AKI depends solely on the ability of the provider to 
assess the relative risk of patients undergoing radiopaque imaging procedures. Those at the 
highest risk for CI-AKI are patients with chronic kidney disease with associated diabetes 
mellitus. Other factors that increase the risk for CI-AKI include congestive heart failure (CHF), 
salt depletion/dehydration, prolonged hypotension, low hematocrit, age > 70 years, multiple 
myeloma, sepsis, and concomitant use of a variety of specific drugs. Table 2 contains a list of 
common risk factors.  
 
Table 2. Common predisposing risk factors for CI-AKI 
 
Preexisting renal dysfunction is the most decisive risk factor in the development of CI-
AKI. Due to the inverse relationship of estimated glomerular filtration rate (eGFR) and the risk 
for CI-AKI, the defined eGFR cut-off point for classifying patients as high risk is ≤ 60 
11 
mL/min/1.73 m² (Tsai et al., 2014). The incidence of CI-AKI in patients with underlying chronic 
renal failure ranges from 14.8 to 55%, and risk can double in patients with concomitant diabetes 
mellitus when compared to nondiabetic patients (Mehran & Nikolsky, 2006).  
Any extrarenal condition that effectively lowers intravascular volume profoundly 
increases the risk of CI-AKI. Conditions that reduce effective intravascular volume include: 
CHF, prolonged dehydration, and salt depletion. CHF activates numerous humoral and 
neurohumoral mechanisms resulting in sodium and water reabsorption by the kidneys. These 
mechanisms result in expansion of extracellular fluid by increasing venous capillary pressure, 
decreasing plasma oncotic pressure, and promoting fluid extravasation and edema formation 
(Navas & Martinez-Maldonado, 1993). Compromised left ventricle systolic performance often 
apparent in CHF patients has also been linked to increased risk of CI-AKI (Gruberg et al., 2000; 
Martin-Paredero et al., 1983). Severe dehydration and salt depletion secondary to abnormal fluid 
losses associated with insufficient salt intake have been shown to play a role in CI-AKI 
(Detrenis, Meschi, Musini, & Savazzi, 2005). Prolonged hypotension as a result of decreased 
effective intravascular volume or induced by antihypertensive treatment using angiotensin-
converting enzyme inhibitors (ACEI), angiotensin-II receptor blockers (ARB), or diuretics 
heighten risk for CI-AKI (Barrett & Parfrey, 1994). Decreased effective intravascular volume 
contributes to CI-AKI risk by reducing renal perfusion and GFR resulting in decreased O2 
delivery and increasing the concentration of RCM within the renal tubules furthering ischemic 
insult and direct cytotoxicity.  
Anemia, or low hematocrit, is an independent risk factor for CI-AKI (J. Y. Cho et al., 
2010; Murakami et al., 2013; Nikolsky et al., 2005). A study of 510 patients indicated that 
individuals with lower hematocrit were more likely to develop CI-AKI (J. Y. Cho et al., 2010).  
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In an earlier study with patients who displayed both reduced eGFR and hematocrit, rates of CI-
AKI were as high as 28.8%, whereas patients with only a diminished eGFR and normal 
hematocrit had significantly lower rates of CI-AKI (Nikolsky et al., 2005). The mechanism for 
increased CI-AKI risk in patients with low hematocrit may be partially attributed to diminished 
oxygen delivery to renal tissue which could increase susceptibility to renal damage. A study of 
200 patients revealed less CI-AKI in patients provided oxygen 10 minutes prior to angiography 
compared to room air (Sekiguchi et al., 2018). These findings suggest sufficient oxygenation 
may be beneficial to reduce renal damage by RCM, but further studies are warranted to explore 
the beneficial effect of oxygen.  
Advanced age is considered an independent predictor of CI-AKI, although the increased 
risk to develop CI-AKI is almost certainly multifactorial (Gussenhoven et al., 1991). Age-related 
alterations in renal function including decreases in GFR, tubular secretion, and urine 
concentrating ability (Denic, Glassock, & Rule, 2016; Sands, 2012) play a role, as well as the 
requirement for larger doses of RCM in elderly patients with calcified vasculature (Mehran & 
Nikolsky, 2006).  
Many radiologists and physicians consider RCM use a contraindication in patients with 
multiple myeloma (Bartels, Brun, Gammeltoft, & Gjorup, 1954; Killmann, Gjorup, & Thaysen, 
1957; Scheitlin, Martz, & Brunner, 1960). CI-AKI in myeloma patients has been attributed to 
precipitation of RCM with Tamm-Horsfall glycoprotein, resulting in increased ischemic injury 
and desquamation of renal proximal tubule (PT) cells (Dawnay et al., 1985). A more recent 
retrospective study reviewed 46 patients with myeloma who underwent RCM-enhanced CT 
scans of the chest, abdomen, and pelvis (Pahade et al., 2011). Of the 46 patients, 12 (26.1%) 
developed CI-AKI; however, there was no significant difference in peak SCr levels in patients 
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that obtained CI-AKI when compared to the patients that did not. Of the parameters obtained, 
only serum levels of β2-microglobulin increase in both patients with high tumor burden and 
decreased renal function indicating a statistically significant correlation with the development of 
CI-AKI. According to the authors, a threshold value of <2.8mg/L of β2-microglobulin could 
essentially eliminate the risk of CI-AKI in patients with multiple myeloma. The European 
Society of Urogenital Radiology concluded multiple myeloma was not a risk factor following 
evaluation of a retrospective study of 13 studies (Stacul et al., 2018). However, ESUR concluded 
that myeloma patients with diminished renal function, dehydration, or hypercalcemia were at a 
much higher risk for CI-AKI (Stacul et al., 2018). 
Sepsis is a life-threatening medical condition most often caused by an overwhelming 
immune response to a body-wide bacterial infection. Sepsis affects both adult and pediatric 
patients and is associated with numerous changes to renal function that may be mediated by 
release of these inflammatory agents as well as direct tubular insult (Alobaidi, Basu, Goldstein, 
& Bagshaw, 2015). Pro-inflammatory cytokines are released into the bloodstream to combat the 
infection triggering widespread inflammation, thrombus formation, and endothelial damage 
(Cavaillon et al., 2003). In cases of septic shock, side-effects include: reduced blood pressure, 
abnormalities in microcirculatory blood flow, coagulopathy, and endothelial dysfunction 
resulting in severely reduced oxygen delivery and organ dysfunction or failure (Angus & van der 
Poll, 2013). However, further studies are needed to evaluate the contribution of renal perfusion 
as animal studies and human studies have reported both increased and decreased renal blood 
flow (Langenberg et al., 2005; Langenberg et al., 2006). Autopsy series fail to detect extensive 
cellular necrosis in victims of septic shock (Takasu et al., 2013); this may be due to sepsis 
promoting mitochondrial damage in renal tubular epithelial cells resulting in decrease oxygen 
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consumption (Tran et al., 2011). In addition to decreased oxygenation, renal epithelium 
experience activation of an innate immune response, giving rise to pathogenic oxidative stress 
and further tissue injury (Wiersinga, Leopold, Cranendonk, & van der Poll, 2014). The use of 
nephrotoxic antibiotics to combat the infection can complicate the diagnosis and treatment of 
sepsis-associated acute kidney injury. Perhaps one, or all, of these factors play a role in why 
patients undergoing radiopaque imaging procedures are at increased risk of sepsis (Matejovic et 
al., 2011). Due to the bidirectional nature of sepsis, additional studies are needed to evaluate the 
connections between CI-AKI and sepsis.    
Concomitant use of drugs that are nephrotoxic or impair kidney function increase the risk 
of CI-AKI. Directly nephrotoxic drugs such as aminoglycosides, cyclosporine A, amphotericin 
B, and cisplatin have been reported to increase kidney susceptibility to RCM-induced toxicity 
(Kolonko, Kokot, & Wiecek, 1998; Morcos, 1998). Aminoglycosides and amphotericin B exert a 
direct nephrotoxic effect via disruption of normal phospholipid trafficking and the induction of 
severe renal vasoconstriction (Fanos & Cataldi, 2000; Swan, 1997). Cyclosporin A impairs 
lysosomal function and damages both proximal and distal convoluted tubules resulting in 
changes to tubulointerstitial transport (Kolonko et al., 1998). Cisplatin, and other platinum 
derivatives, impair proper enzyme function by binding to sulfhydryl groups resulting in direct 
toxicity to PT cells (Hanigan & Devarajan, 2003). Long-term ingestion of high doses of 
NSAIDs, certain penicillins, and sulfonamides can lead to acute tubulointerstitial nephritis which 
increases the risk of CI-AKI (Kolonko et al., 1998; Morcos, 1998). Although the role of ACEIs 
and ARBs in CI-AKI is controversial, many providers still believe that concomitant use should 
be avoided (Toprak, 2007). According to the Council on the Kidney in Cardiovascular Disease 
and the Council for High Blood Pressure Research of the American Heart Association, the use of 
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ACEIs or ARBs in radiopaque imaging procedures depends on multiple factors. If the patient’s 
renal perfusion pressure is adequate and volume depletion is not severe, the use of ACEIs or 
ARBs is acceptable and can even improve renal hemodynamics and salt excretion. However, 
angiotensin II is essential in the autoregulation of GFR and renal perfusion, and the use of these 
agents in hypovolemic patients can induce a dramatic decrease in GFR and subsequent oliguric 
or anuric renal failure (Schoolwerth et al., 2001). Conversely, the Kidney Disease Improving 
Global Outcomes Clinical Practice Guideline for Acute Kidney Injury states that there is not 
enough evidence to recommend the discontinuation of ACEIs or ARBs prior to RCM 
administration(Kellum, 2012). Loop diuretics, specifically furosemide, have been shown to 
increase the risk of CI-AKI (Majumdar et al., 2009). Other studies have stated that although loop 
diuretic exposure is associated with acute kidney injury in hospitalized patients, the change in 
renal function is small and loop diuretic use does not explain the variability in overall renal 
function (El-Refai et al., 2011). 
CYTOTOXICITY 
The cytotoxic effects of RCM on PT cells have been extensively studied. The most 
commonly reported responses to the interaction between RCM and PT cells are vacuolization of 
the PT cells, increased production of ROS and induction of oxidative stress, mitochondrial 
dysfunction and an ensuing decline in ATP production, activation of the UPR and ER stress, and 
alterations in activity of stress kinases (Andersen, Christensen, & Vik, 1994; Andersen, Vik, 
Eikesdal, & Christensen, 1995; Tervahartiala et al., 1997; Tervahartiala et al., 1991).  
Epithelial PT cell vacuolization is generally interpreted as an indicator of drug toxicity 
and is a histopathological feature of CI-AKI. One route in which RCM are influxed into PT cells 
is via pinocytosis. During the process of urine production, RCM is concentrated in the renal 
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tubules. As a result, PT cells are exposed to increasing concentrations of RCM, inducing a rise in 
pinocytic vessels containing RCM, formation of large vacuoles, alterations in renal histology, 
and epithelial damage (Andreucci, Solomon, & Tasanarong, 2014; Dickenmann, Oettl, & 
Mihatsch, 2008). An early study on vacuolization of PT in response to RCM demonstrated that 
male Sabra rats experienced vacuolar changes in the early segments of the PT within 120 
minutes of administration to 2.9 g I/kg of iothalamate. The changes were described as being 
similar in nature and closely resembled what has been described in human contrast nephropathy 
(Heyman et al., 1988). A study performed by Tervahartiala et al. demonstrated that 3 g I/kg of 
diatrizoic acid or iopromide induced statistically significant PT cell vacuolization within 2 hours 
of administration in diabetic Wistar rats of both sexes (Tervahartiala et al., 1991). Iohexol and 
iotrolan caused longer lasting and more pronounced vacuolization (Tervahartiala et al., 1991). A 
separate study on male Sprague-Dawley rats showed a low-level increase in cytoplasmic 
vacuoles in PT cells occurred in as little as 5 minutes and continued to increase in size and 
number for 24 hours after single-dose administration of 3 g I/kg iotrolan (Rees, Old, & 
Rowlands, 1997). A more modern study performed on male Wistar rats demonstrated that a 
concentration as low as 10ml/kg of iodixanol can induce vacuolization in PT cells in 24 hours 
(Nasri et al., 2015). Although RCM from each generation induce vacuolization, the lack of in 
vitro studies makes it impossible to determine if this is a direct toxic side effect of RCM.  
CI-AKI is the result of a combination of alterations in renal hemodynamics and toxic 
renal parenchymal damage. Aside from hypoxia induced by low oxygen supply, it is believed 
that the latter of the two is due to oxidative stress induced by an increase in ROS. Additionally, 
exposure to RCM results in diminished availability and activity of cellular antioxidant systems. 
Under physiological conditions, the production of ROS within renal parenchyma is connected to 
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tubular transport, specifically in areas of the nephron that have dense mitochondrial populations 
such as the PT, the convoluted tubules, or the TAL of the nephron. A major source of production 
of superoxide anions (O2•─) and hydroxyl radicals (OH─) takes place within the mitochondria via 
NAD(P)H-oxidases (Heyman et al., 2010). Additionally, as the consumption of oxygen begins to 
overwhelm available oxygen during periods of hypoxia, there is an increase in the complete 
conversion of ATP to hypoxanthine by 5’-nucleotidase. From this, hypoxanthine is converted to 
uric acid and hydrogen peroxide (H2O2) via xanthine oxidase. Consequently, H2O2 and O2•─ can 
react with NO to form peroxynitrite leading to renal vasoconstriction and epithelial damage by 
decreasing the vasodilatory effects of NO and interacting with protein and DNA, respectively. 
Although there is evidence that peroxynitrite can induce a degree of vasodilation initially, long-
term exposure to peroxynitrite in an environment devoid of NO can lead to irreversible 
endothelial and epithelial damage (Pacher, Beckman, & Liaudet, 2007). 
Several experimental studies have shown that exposure of renal cells to RCM enhances 
ROS production resulting in oxidative stress. Huang and colleagues noted that exposure of a 
non-cancerous, immortalized human renal proximal tubule epithelial cell line (HK-2) to the 
HOCM ioxitalamate induced an increase in cytoplasmic ROS production and formation of 8-
hydroxy-2’-deoxyguanosine (8-OHdG), indicating oxidative damage following a 48 hour 
treatment (Huang et al., 2016). A significant increase of cytosolic superoxide formation took 
place only 2 hours after exposure of HK-2 cells to 150 mg I/mL of the LOCM iohexol (Jeong et 
al., 2018). A similar study using a canine distal convoluted tubule cell line (MDCK) showed that 
exposure to 50, 100, or 200 mg I/mL of iobitridol, iopamidol, or iodixanol induced a dose-
dependent increase in ROS production within 3 hours (Quintavalle et al., 2011). A study 
performed by Netti et al. demonstrated that a statistically significant increase NADPH oxidase-
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dependent ROS can be seen in HK-2 cells within 30 minutes of exposure to 200 mg I/mL of 
LOCM iohexol or iopamidol (Netti et al., 2014). An increase in intracellular ROS can be seen 
regardless of generation of RCM.  
Although there are several in vitro studies pertaining to the effect of RCM on the 
production of ROS, very little has been done to examine the source of ROS production. A rise in 
ROS concentrations could be, in part, due to a reduction in the efficacy of intracellular 
antioxidant systems. Figure 3 shows the intracellular antioxidant systems. At the time of this 
review, a study performed by Jeong et al. is a lone study examining RCM effects on intracellular 
antioxidant systems in vitro. The Jeong group determined that HK-2 cells exposed to 150 mg 
I/mL of iohexol induced a significant decrease in manganese superoxide dismutase (MnSOD) 
and glutathione peroxidase (GPx) after 2 hours (Jeong et al., 2018). It is apparent that there is a 
significant gap in knowledge pertaining to the effects of RCM on antioxidant systems in vitro; 
however, the effects of RCM on reduced glutathione (GSH), GPx, MnSOD, and Catalase (CAT), 
have been studied extensively in vivo. A study performed by Gong et al. determined that male 
Sprague-Dawley rats exposed to 1.5-2 g I/kg of iohexol resulted in a decrease MnSOD and GSH 
after 24 hours (Gong et al., 2016). Tasanarong et al. showed in a similar study that exposing 
male Sprague-Dawley rats to 1.6 g I/kg of iopromide induced a significant decrease in MnSOD 
and CAT after 24 hours(Tasanarong, Kongkham, & Itharat, 2014). GSH, GPx, MnSOD, and 
CAT were all significantly reduced in male Sprague-Dawley rats exposed to 3 g I/kg of 
iodixanol (N. Liu et al., 2018). It should be stated that these changes in cellular oxidant defenses 
may not be a direct result of RCM toxicity and could be induced, in part, by alterations in renal 
hemodynamics. Taken together, increased ROS production and a decrease in the efficacy of 
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renal antioxidant systems plays an important role in CI-AKI; however, the effects of RCM on 
antioxidant systems on in vitro systems needs to be studied more in depth. 
 
 
Figure 3. ROS scavenging pathways in renal epithelial cells.  
 
Under normal physiological conditions, the mitochondria are one of the main sources of 
intracellular ROS and the main organelle target for ROS (Cho, Nakamura, & Lipton, 2010). 
Previous studies indicate that mitochondrial injury plays an important role in various types of 
acute kidney injury (Tang et al., 2018; Xiao et al., 2014). Humes et al. noted that PT segments 
isolated from New Zealand white rabbits incubated with diatrizaote demonstrated significant 
reductions in basal and uncoupled respiration and intracellular ATP levels indicating an 
interaction between diatrizoic acid and PT cell mitochondria (Humes, Hunt, & White, 1987). A 
follow up study using the same model compared the mitochondrial toxicity of diatrizoic acid and 
iopamidol (Messana, Cieslinski, Nguyen, & Humes, 1988). The authors determined that 
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diatrizoic acid induced greater reductions in intracellular ATP, basal respiration, and uncoupled 
respiration when compared to iopamidol and both RCM were toxic when compared to control. 
Messana et al. continued their studies of the effects of RCM on isolated proximal tubules by 
comparing the mitochondrial toxicity of the non-ionic monomer iopamidol and ionic dimer 
ioxaglate. The authors determined that both RCM induced mitochondrial damage but the 
differences in direct nephrotoxic potential become insignificant when normalized for iodine 
content (Messana, Cieslinski, & Humes, 1990). Exposure of a porcine kidney cell line that 
express characteristics similar to PT cells (LLC-PK1) to ioversol caused depolarization of 
mitochondrial membranes and stimulated the release of cytochrome c activating caspase-9 
through the action of the adaptor molecule apoptotic protease-activating factor-1 (Itoh et al., 
2006). Lei et al. determined that exposure to iohexol or iodixanol induced a significant increase 
in mitochondrial ROS and mitochondrial membrane potential in HK-2 cells (Lei et al., 2018). An 
in vivo investigation on the effects of RCM on the electron transport chain determined that 
exposure of male Wistar albino rats to 1.95 g I/mL of diatrizaote induced decreased activity in 
complex I and complex III within the kidneys, although not to a significant degree (Roza et al., 
2011). As one would expect, significant mitochondrial dysfunction results insufficient ATP for a 
cell to maintain its cellular functions resulting in activation of the intrinsic apoptotic pathways; 
however, the source of mitochondrial dysfunction in response to RCM exposure has yet to be 
identified (Haller & Hizoh, 2004). 
The primary role of the ER is the synthesis and folding of secreted, membrane-bound, 
and some organelle-targeted proteins. The environment within the ER is optimal for protein 
folding and management, as well as ATP storage and calcium transport (Gaut & Hendershot, 
1993). Perturbations of cellular ATP levels, calcium concentration, and/or the redox status within 
21 
a cell can lead to a decline in the protein folding ability of the ER (Bravo et al., 2013). An 
accumulation of unfolded or misfolded proteins activates a pro-survival response responsible for 
restoring protein folding function within the ER called the unfolded protein response (UPR) 
(Schroder & Kaufman, 2005). Prolonged activation of the UPR will promote a shift from pro-
survival to pro-apoptotic signaling, designated ER stress (Szegezdi, Logue, Gorman, & Samali, 
2006). ER stress can lead to the activation of multiple signaling pathways that induce cellular 
apoptosis (Figure 4) and its role in CI-AKI has recently become a topic of interest. An initial 
study performed by Wu et al. determined the effects of diatrizoic acid on rat renal proximal 
tubule cells (NRK52E). Exposure of NRK52E cells to 40 mg I/mL of diatrizoic acid induced an 
increase in multiple ER stress markers including glucose-regulated protein 78 (GRP78), RNA-
dependent protein kinase-like ER kinase (PERK), and inositol-requiring ER-to-nucleus signal 
kinase 1 (IRE1) within 24 hours (Wu et al., 2010). An additional study by Wu et al. on NRK52E 
cells determined that 40 mg I/mL of diatrizoic acid induced significant increases in the ER stress 
markers activating transcription factor 6 (ATF6), C/EBP homologous protein (CHOP), and the 
ER stress dependent caspase, caspase-12 within 24 hours (Wu et al., 2013). Peng et al. showed 
that HK-2 cells exposed to 40 mg I/mL of diatrizoic acid induced statistically different increases 
in GRP78, activating transcription factor 4 (ATF4), CHOP, and caspase-12 within 4 hours (P. A. 
Peng et al., 2015).  
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Figure 4. Pathways involved in the UPR.  
 
Mitogen-activated protein kinases (MAPKs) such as the extracellular signal-regulated 
kinases (ERK1/2 or p42/44MAPK), the c-Jun N-terminal kinases (JNK1/2), and p38MAPK have 
been shown to be activated in response to ROS (Matsuzawa & Ichijo, 2008; Robinson & Cobb, 
1997). The ERK1/2 cascade is activated in response to mitogenic and survival stimuli, whereas 
JNK1/2 and p38MAPK pathways are stimulated in response to cellular stresses including 
oxidative agents, hypoxia, UV radiation, and pro-inflammatory cytokines (Ichijo, 1999; Ip & 
Davis, 1998). Previous studies have shown that renal epithelial cell exposure to RCM results in 
activation of the intrinsic apoptotic pathway (Romano et al., 2008). An extensive study 
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performed by Quintavalle et al. demonstrated the role of stress kinases in the activation of this 
pathway. MDCK cells were exposed to 50, 100, or 200 mg I/mL iobitridol, iopamidol, or 
iodixanol for 3 hours to determine the effect of RCM on stress kinases. Each of the tested RCM 
induced a dose-dependent increase in phosphorylated JNK and p38MAPK within 1 hour, 
indicating that exposure to RCM does induce activation of the pro-apoptotic stress kinases. The 
role of JNK and p38MAPK were verified in two methods: pretreating the MDCK cells with the 
p38 inhibitor SB203580 or transfecting MDCK cells with kinase-dead mutants for p38 or JNK. 
MDCK cells pretreated with SB203580 or transfected with kinase-dead mutants were completely 
protected from apoptotic effects of all three RCM verifying the role of stress kinases in CI-AKI 
(Quintavalle et al., 2011). Another study confirming Quintavalle’s findings demonstrated that 
pretreating HK-2 cells with JNK inhibitor SP600125 or p38 inhibitor SP283580 significantly 
decreased cleaved caspase-3 activation and increased pro-survival protein bcl-2 after exposure to 
200 mg I/mL iopamidol (X. He et al., 2016). A more recent study on LLC-PK1 cells determined 
that 25 mg I/mL of iodixanol will induce increases in activated p38MAPK, JNK, and ERK after 
24 hours of exposure (Lee et al., 2018).  
Additional kinases important to cellular survival that are affected by RCM exposure 
include protein kinase B (Akt), PTEN-induced putative kinase (PINK1), Rho-associated protein 
kinase (ROCK), Janus kinases (JAK) and signal transducer and activator of transcription proteins 
(STATs). A study performed by Xie et al. on the effects of ioversol on HK-2 cells indicated that 
a 30 minute exposure to 100 mg/ml of ioversol significantly decreases the presence of 
phosphorylated Akt while simultaneously inducing caspase-3 cleavage and apoptosis (Xie et al., 
2017). This discovery demonstrates that the phosphoinositide-3 kinase (PI3)/Akt pathway may 
play a role in cellular fate after exposure to RCM. Renal tissues extracted from male Sprague-
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Dawley rats that were exposed to 12.25 g I/kg iohexol demonstrated a significant increase of 
PINK1 (X. Yang et al., 2018). Activation of PINK1 indicates an increase in mitophagy resulting 
in decreased ATP production and energy failure. ROCK plays an important role in various 
cellular processes including: cell adhesion, migration, proliferation, cytokine activation, 
inflammatory cell migration, smooth muscle cell contraction and cell cycle regulation. Inhibition 
of Rho-ROCK pathways has been shown to diminish CI-AKI in vivo (Su et al., 2014; Wang et 
al., 2018); however, the relationship of CI-AKI and ROCK has not been explored in vitro. The 
role of JAK-STAT pathway was determined in a study performed by Yokomaku et al. 
Pretreating male Sprague-Dawley rats or LLC-PK1 cells with asialoerythropoietin or 
erythropoietin activated JAK2 and STAT5 and attenuated ioversol-induced nephropathy or 
cellular injury indicating that the JAK-STAT pathway may play a role in CI-AKI (Yokomaku et 
al., 2008). 
Calcium overload within renal parenchyma is also thought to play a role in CI-AKI via 
ROS overproduction, p38 MAPK activation, and endothelin activation and release (Duan et al., 
2000; Humes et al., 1987; Jin et al., 2015; Schick, Bangert, Kubler, & Haller, 2002; D. Yang & 
Yang, 2013). However, the initial source of intracellular calcium overload has not been fully 
elucidated and could result from ER or mitochondrial dysfunction, inhibition of the Na/K-
ATPase, or changes in function of the Na/Ca exchanger system  (Krebs, Agellon, & Michalak, 
2015; D. Yang & Yang, 2013; D. Yang, Yang, Jia, & Ding, 2013). 
INTERVENTIONS FOR CYTOTOXICITY BY HYDRATION, DRUGS, AND NATURAL 
PRODUCTS 
Adequate hydration is the gold standard for prevention of CI-AKI. The rationale is that 
forced or adequate hydration induces an expansion of intravascular volume, suppression of 
renin-angiotensin cascade, reduction of renal vasoconstriction and hypoperfusion, and increases 
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urine output (Andreucci, Faga, et al., 2014). Higher urine output is associated with a lower 
incidence of CI-AKI due to the decreased time of tubular RCM exposure (Solomon & 
Dauerman, 2010). Unfortunately, high infusion rates or increased total extracellular volumes can 
result in a volume overload and initiate pulmonary edema in patients with preexisting cardiac 
impairment (S. Q. Chen et al., 2018). Due to the considerable dissent in the medical community 
pertaining to acceptable preventative measures for CI-AKI, substantial research has gone into 
finding a potential nephroprotective agent.  
The most explored strategy in the prevention of CI-AKI is the use of antioxidants to 
decrease contrast-induced oxidative stress. Common antioxidants have been studied including N-
acetylcysteine (NAC), ascorbic acid, and α-/γ-tocopherol. In vitro studies have provided 
consistent results for protection by NAC. A study performed by Romano et al. demonstrated the 
protective effects of NAC on LLC-PK1, MDCK, and human embryonic kidney cells (HEK-293) 
against IOCM and LOCM. At a concentration of 200 mg I/mL of iobitridol and iodixanol and an 
incubation time of 3 hours, pre-treatment with NAC protected the three cell lines from RCM-
induced apoptosis in a dose dependent manner (Romano et al., 2008). Yang et al. demonstrated 
that NRK-52E cells pretreated with low concentration NAC (10 mmol/L) before being exposed 
to 50, 100, and 150 mg I/mL of iopromide for 4 hours significantly decreased early stage 
apoptosis as seen by Annexin V and propidium iodide (PI) staining (Y. Yang et al., 2014). The 
Romano et al. study mentioned above also examined the protective effects of ascorbic acid 
(vitamin C) in vitro. The authors demonstrated that a 2 hour pretreatment with ascorbic acid 
prevented high concentration IOCM- and LOCM-induced apoptosis in a dose-dependent fashion; 
however, NAC was more effective than ascorbic acid at preventing RCM-induced cytotoxicity 
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(Romano et al., 2008). Unfortunately, the protective effects of α-/γ-tocopherol on CI-AKI have 
not been studied in vitro.  
Although certain antioxidants have shown to be protective against CI-AKI in vitro, the 
results from a clinical standpoint are inconclusive. Numerous clinical studies have shown NAC 
to be a potentially effective strategy for the prevention of CI-AKI (Briguori et al., 2007; Briguori 
et al., 2004; Tepel et al., 2000); other studies have concluded that NAC alone or in combination 
with ascorbic acid was not beneficial to patients (Palli et al., 2017; Yeganehkhah et al., 2014).  
Further studies are needed to evaluate the long-term clinical benefits in patients as a study in 
over 5000 patients concluded that acetylcysteine was not beneficial when evaluating outcomes 
90 days after angiography in high renal risk patients (Weisbord et al., 2018). Antioxidant 
vitamins α-/γ-tocopherol (Vitamin E) have also been shown to be useful in the prevention of CI-
AKI in a clinical setting (Briguori et al., 2007; Spargias et al., 2004; Tasanarong, Vohakiat, 
Hutayanon, & Piyayotai, 2013). A study performed by Kongkham et al. on male Sprague-
Dawley rats demonstrated that pretreatment with 250 or 500 mg Vitamin E prior to induction of 
CI-AKI with 1.6 g I/kg iopromide significantly decreased tubular necrosis, PT cell congestion, 
and interstitial edema while simultaneously increasing total antioxidant capacity and MnSOD 
activity when compared to non-pretreated rats (Kongkham, Sriwong, & Tasanarong, 2013).  
HMG-CoA reductase inhibitors, or statins, are a class of lipid lowering medications 
specifically used in the treatment of cardiovascular disease. Statins are thought to protect against 
RCM cytotoxicity by increasing heme oxygenase-1 production and diminishing the activity of 
NADPH oxidase, resulting in the reduction of ROS formation and oxidative stress induced by 
RCM (Grosser et al., 2004; Stoll, McCormick, Denning, & Weintraub, 2004). A sole in vitro 
study performed by Quintavalle et al. on the nephroprotective effects of atorvastatin determined 
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that MDCK and HK-2 cells pretreated with 0.2 μM atorvastatin for a minimum of 6 hours 
induced a significant increase in cell viability and subsequent decrease in RCM-induced 
apoptosis after a 3 hour exposure to 200 mg I/mL iodixanol (Quintavalle et al., 2012). This class 
of pleiotropic drugs may also be an effective pretreatment in reducing the incidence of CI-AKI 
as seen by various clinical studies (Jo et al., 2008; Toso et al., 2010; Tropeano et al., 2016). 
Pharmacologic agents used primarily for the treatment of hypertension such as nebivolol, 
ACEIs, and ARBs have garnered some interest in the prevention of CI-AKI. Nebivolol is a third 
generation β1-receptor antagonist that may protect the kidney via its antioxidant and NO-
mediated vasodilating properties (Toprak et al., 2008). Toprak et al. determined the efficacy of 
nebivolol in preventing CI-AKI initially in female Wistar albino rats pretreated with 2 mg/kg of 
nebivolol once daily for 5 consecutive days prior to administration of 6 ml/kg of diatrizoic acid 
on the fourth day. Pretreatment with nebivolol resulted in a reduction of tubular necrosis, 
medullary congestion, and tubular casts, as well as an increase renal NO levels in rats when 
compared to rats that did not receive nebivolol (Toprak et al., 2008). A more recent study 
followed the Toprak et al. study design and determined that pretreatment with nebivolol prior to 
administration of RCM significantly reduced advanced oxidation protein products and 
malondialdehyde in serum and kidney tissue and increased total serum NO concentration (Koc et 
al., 2011). The role of the renin-angiotensin-aldosterone system (RAAS) and RAAS-blocking 
drugs in CI-AKI is controversial. This is due to experimental data suggesting that ACEIs or 
ARBs protect the kidneys from RCM-induced nephrotoxicity while other claims that RAAS-
blocking drugs are nephrotoxic and worsen CI-AKI (Ikeda et al., 2006; Patel, King, & Jovin, 
2011; Rosenstock et al., 2008). A large prospective study performed by Holscher et al. evaluated 
CI-AKI predictors and long-term outcomes of high-risk patients. The authors noted that 
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decreased eGFR, the use of ACEIs, and post-procedural hemodialysis were independently 
associated with increased incidence of CI-AKI (Holscher et al., 2008). The overall lack of in 
vitro experimentation pertaining to high blood pressure medications is troubling when compared 
to the amount of clinical data that has been collected. This is an area where more research is 
necessary to make an accurate prediction of the possible mechanisms involved.  
The administration of naturally derived compounds in the prevention of CI-AKI has 
shown considerable promise in recent years. Polyphenolic compounds such as resveratrol, 
salvianolic acid B, epigallocatechin gallate (EGCG), flavonoids compound found in Artemisia 
argyi, the xanthone compound α-mangostin all demonstrated protective effects against CI-AKI in 
vitro. Resveratrol, a compound found in grape skins, significantly reduced HK-2 cytotoxicity 
induced by ioxithalamate after 48 hour exposure (Huang et al., 2016). Salvianolic acid B, derived 
from the traditional Chinese medicine Danshen, decreased renal epithelial damage in male 
Sprague-Dawley rats exposed to iohexol (Tongqiang et al., 2016). In a similar fashion to 
salvianolic acid B, EGCG, the major antioxidant component of green tea, reduced the damage 
induced by iopromide in male Sprague-Dawley rats (Z. Gao et al., 2016). A study performed by 
Lee et al. demonstrated that the flavonoid components of Artemisia argyi, also called mugwort, 
completely prevented the cytotoxic effects induced by iodixanol on LLC-PK1 cells (Lee et al., 
2018). A separate study performed by Lee et al. showed that non-toxic concentrations of α-
mangostin, found in mangosteen, improved the viability of iodixanol treated LLC-PK1 cells by 
90.42% against contrast-induced apoptotic damage (Lee et al., 2016). It is apparent that the 
nephroprotective effects of certain naturally derived compounds can prevent contrast-induced 
cytotoxicity both in vitro and in vivo. 
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CONCLUSIONS 
RCM are non-biologically active compounds necessary for a multitude of diagnostic 
imaging procedures. Modern RCM induce severe and prolonged vasoconstriction within the 
renal medulla and are directly toxic to the extremely metabolically-active renal epithelium such 
as PT cells and the TAL. Exposure to RCM and the consequential epithelial damage results in an 
increase in ROS and oxidative stress, vacuolization of tubular cells, damage to the mitochondria 
in the form of decreased respiration and ATP production, perturbations in the protein folding 
capacity of the ER resulting in activation of the UPR and ER stress, and decreased activity of 
survival kinases and activation of pro-apoptotic stress kinases. Current measures to ensure the 
prevention of CI-AKI are lacking and considerable research needs to be invested into in vitro 
studies to determine the source of direct RCM induced cytotoxicity. 
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CHAPTER 2: GENERAL METHODS, MATERIALS, AND STATEMENT OF 
HYPOTHESIS 
 
THE HK-2 CELL MODEL 
To determine the direct cytotoxicity of DA, a system that is devoid of the renal 
hemodynamic and inflammatory responses to RCM is necessary. Thanks to doctoral work 
previously done in our laboratory (Murphy et al., 2017), we had the advantage of having a well-
documented in vitro model focused on nephrotoxicity to use for my dissertation research. Human 
kidney 2 (HK-2) cells are an immortalized, noncancerous, human epithelial proximal tubule cell 
line that maintains biochemical properties and activity similar to human proximal tubules in situ 
(Gunness et al., 2010; Paolicchi et al., 2003; Ryan et al., 1994). HK-2 cells retain functioning 
organic ion transporters (OAT) 1 and 3, which have been reported to transport DA into proximal 
tubule cells (Mudge, Berndt, Saunders, & Beattie, 1971) and have been used as a widely 
accepted model for CI-AKI studies (Haeussler, Riedel, & Keller, 2004; Zager, Johnson, & 
Hanson, 2003).  
HK-2 cells were purchased from the American Type Culture Collection (ATCC, 
Manassas, VA, CRL-2190) and were cultured according to ATCC guidelines. Cells were grown 
according to ATCC recommended conditions of keratinocyte-free media with added bovine 
pituitary extract (50 μg/mL) and recombinant epithelial growth factor (5 ng/mL) purchased from 
Fisher Scientific (Gibco, Carlsbad, CA, Item No. 17005-042). Cells were grown in a warm, 
humidified incubator at 37°C with 5% CO2.  
EXPERIMENTAL PROTOCOL 
For all experiments, HK-2 cells were plated into T75 flasks, 6 well plates, 96 well plates, 
or XFe and XFp Culture Miniplates at a cellular density of 1.0x106, 5x105, 37,000, and 1.75x105 
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cells/mL, respectively, and allowed to equilibrate for 48 hr in a warm, humidified incubator set 
to 37°C with 5% CO2. Media was subsequently replaced, and cells were treated with a final 
concentration of 0, 2, 5, 10, 15, 18, 23, 28, or 30 mg I/mL DA for 2, 8, or 24 hr. Due to the fact 
that preparations of RCM vary based on iodine concentration, manufacturer, and viscosity, units 
of RCM are conventionally expressed as mg I/mL to maintain iodine dose and bolus compaction 
in a clinical setting (Faggioni & Gabelloni, 2016). Vehicle control was an equal volume of PBS. 
The concentrations used are levels of DA that are found within the plasma of a healthy 75 kg 
man after intravenous administration, depending on procedure. A literature review indicates that 
the concentrations used in this study are far less than what is currently being used in other 
mechanistic studies. Some studies use concentrations as high as 150 mg I/mL to induce direct 
cytotoxicity (Jeong et al., 2018; Y. Yang et al., 2014). Exposing HK-2 cells to a concentration 
closer to what proximal tubule cells experience in situ following an imaging procedure better 
represents the renal damage observed in a clinical setting.  
HK-2 cells were exposed to clinically relevant concentrations of DA for 2, 8, or 24 hr. 
These time points were decided upon based on the half-life of DA. Theoretically, following 
administration of RCM, the tubular epithelium of a patient with a GFR > 60 mL/min is exposed 
to RCM for approximately 8 hr; however, as the viscosity of RCM rises the amount of time the 
kidney could experience a DA-induced insult can increase for up to 24 hr. Following the 
exposure period, cells were either collected for trypan blue exclusion, isolation of cellular 
fractions, protein expression analysis, SOD activity assays, and calpain activity assays or used 
for MTT assays or Agilent Seahorse cellular energy assays.  
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GENERAL PROTOCOL FOR WESTERN BLOTTING AND OXYBLOT® 
Following the DA exposure period, cells were collected, lysed, and protein levels were 
determined using the Bradford protein assay (discussed below) (Bradford, 1976). Western blots 
were performed as follows: 40 µg aliquots of cell lysate were diluted to 25 µl with double 
distilled H2O (denoted from this point on as H2O) followed by the addition of 25 µl reducing 
sample buffer (RSB). In scenarios where the volume of cell lysate was greater than 25 µL prior 
to dilution with H2O, the sample aliquots were placed into microcentrifuge tubes and lyophilized 
in a vacuum at -107°C. The lyophilized samples were reconstituted in 25 µL H20 and 25 µL 
RSB. The samples were then denatured in boiling water for 5 min. After the denaturation step, 
samples were separated via gel electrophoresis on a 12.5% polyacrylamide gel and transferred to 
a 0.45 µM nitrocellulose membrane (Bio-Rad; Hercules, CA, Item No. 1620115). MemCode® 
staining was used to verify transfer of equal protein loading and standardize the densitometry to 
total protein in each of the lanes. Protein staining was used as an alternative to standard 
housekeeping proteins such as GAPDH or actin due to more reliable results in toxicological 
studies (Zhang et al., 2019).  
Membranes were then blocked using 1% bovine serum albumin (BSA) or 5% milk 
dissolved in TBST (10 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20; pH 8.0) or PBST (8mM 
Na2HPO4, 0.15M NaCl, 2mM KH2PO4, 3mM KCl, 0.1% Tween-20; pH 8.0) for 1 hr. All of the 
antibodies used in the current work can be found in Table 3. The membrane was then washed 
with TBST or PBST three times for ten min each followed by the addition of secondary 
antibody. After another round of three washes, the membrane was developed using Amersham 
ECL Western Blotting Detection Agent (GE Healthcare Life Sciences, Marlborough, MA, Item 
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No. RPN2232). A BioRad chemic-doc system was used to capture the gel image and used for 
densitometry analysis (version 4.0.1, Bio-Rad, Hercules, CA, Catalog No. 170-9690). 
The OxyBlot® (EMD Millipore; Burlington, MA, Item No. S7150) procedure requires a 
derivatization step. Protein carbonyls within each sample are derivatized to 2,4-
dinitrophenylhydrazine (DNPH) and can then be measured using an antibody that recognizes 
DNPH.  
Table 3. Primary and secondary antibodies used in current work.  
 
SEAHORSE XFe ASSAYS 
The Agilent Seahorse XFe analyzer allows for real-time measurements of cellular 
metabolic function in cultured cells. Oxygen Consumption Rate (OCR) and Extracellular 
Acidification Rate (ECAR) are measured to interrogate key cellular functions such as 
mitochondrial respiration and glycolysis. Mitochondrial function and glycolysis were measured 
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using Agilent cell mito stress tests, cell glycolysis stress tests, mito fuel flex tests, and real-time 
ATP rate assays following optimization of cell number per well. 
HK-2 cells were cultured in XFe Culture Miniplates (175,000 cells/mL) (Agilent 
Technologies, Item No. 101085-004) and allowed to grow for 48 hr followed by treatment with 
vehicle or DA. Prior to the assay, cells were washed with assay media (Agilent Technologies, 
Santa Clara, CA, Item No. 103575-100) supplemented with 1 mM glucose (Agilent 
Technologies, Item No. 103577-100), 1 mM pyruvate (Agilent Technologies, Item No. 103578-
100), and 2 mM glutamine (Agilent Technologies, Santa Clara, CA, Item No. 103579-100) and 
equilibrated in 175 or 180 μL pre-warmed assay media at 37°C devoid of CO2 for 45 min.  
In each assay, three basal OCR/ECAR measurements were taken at three minute intervals 
using the Seahorse XFe instrument system. Following basal measurements, various probes were 
injected and additional OCR and ECAR measurements were taken. Oligomycin, an ATP-
synthase inhibitor, was used to stimulate glycolysis and the final step of the electron transport 
chain. Maximal respiration was stimulated by the addition of carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), an uncoupler of mitochondrial oxidative 
phosphorylation that moves protons across the mitochondrial inner membrane. The complex I 
and complex III inhibitors rotenone and antimycin-A, respectively, were used to completely 
inhibit mitochondrial respiration. The hexokinase inhibitor, 2-deoxyglucose, was used as an 
inhibitor of glycolysis. The cell mitochondrial stress test (Agilent Technologies, Item No. 
103015-100), initially inhibits ATP synthase with an injection of oligomycin (0.5 μM), FCCP 
(0.5 μM), followed by complete inhibition of the electron transport chain by injection of a 
mixture of rotenone/antimycin-A (0.5 μM) and mitochondrial function was assessed by 
continuous measurement of OCR (Figure 5). Preliminary studies for FCCP indicated a final 
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concentration of 0.5 μM was optimal. The cell glycolysis stress test (Agilent Technologies, Item 
No.103020-100), utilizes glucose (10 mM), oligomycin (1 μM), and 2-DG (50 mM) followed by 
continuous OCR and ECAR measurements to assess parameters of glycolysis. The real-time 
ATP rate assay (Agilent Technologies, Item No. 103592-100), uses serial injections of 
oligomycin (1.5 µM) and a mixture of rotenone/antimycin-A (0.5 μM) followed by continuous 
OCR and ECAR measurements to asses total ATP, mitochondrial-linked ATP, and glycolysis-
linked ATP production. The mito fuel flex test (Agilent Technologies, Item No. 103260-100), 
utilizes UK5099, BPTES, and Etomoxir injections followed by continuous OCR measurements 
to determine mitochondrial fuel source oxidation. Following each assay, cells were washed with 
200 μL PBS and lysed. Total number of cells were measured using the CyQUANT Cell 
Proliferation Kit (Invitrogen, Carlsbad, CA, Item No. C7026). Results were normalized to 
number of cells and analyzed using Wave Software (Agilent Technologies, Wave for Desktop, 
Version 2.5.0.6). 
 
Figure 5. Agilent Seahorse XF cell mito stress test profile and electron transport chain. Key 
parameters of mitochondrial function shown by the Agilent Seahorse cell mito stress test profile 
(A). Effects of the cell mito stress test modulators on the electron transport chain (B). 
https://www.agilent.com/cs/library/usermanuals/public/XF_Cell_Mito_Stress_Test_Kit_User_G
uide.pdf 
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CELL AND PROTEIN NORMALIZATION 
 Protein concentration in cell lysates, mitochondrial fractions, and SOD activity assays 
were determined using the Bradford assay (Bradford, 1976). A 5 or 11 µL aliquot of cell lysate 
or mitochondrial lysate was diluted with 45 or 11 µL ddH20, respectively. An aliquot of 16 µL of 
lysate mixture was then mixed with 784 µL Coomassie Blue, and a 200 µL aliquot was pipetted 
into a 96-well plate in triplicate. Protein concentration was then determined by comparing the 
absorbance of the samples to the absorbances of a standard curve using 100, 200, 400, and 600 
mg/mL BSA in H20. Western blots, OxyBlots, and SOD activity assays were normalized using 
constant loading concentrations and volumes.  
 Agilent Seahorse and calpain activity assays were normalized using CyQUANT® Direct 
Cell Proliferation Assay (ThermoFisher Scientific). Immediately following the completion of a 
specific Seahorse assay, the media was removed via aspiration and the Culture Miniplate was 
stored in a -80°C freezer overnight. The CyQUANT assay utilizes CyQUANT GR dye which 
produces a large fluorescence enhancement upon binding to cellular nucleic acids that can be 
measured using standard fluorescein excitation (485 nm) and emission (530 nm) wavelengths. 
The fluorescence emission of the dye-nucleic acid complexes correlated linearly with cell 
number over a large range using a wide variety of cell types (Jones et al., 2001). 
STATISTICAL ANALYSIS 
All values are reported as mean ± SEM with at least 3 independent experiments 
conducted from at least 2 biological replicates. Differences between groups were determined 
with a one-way or two-way ANOVA followed by a Holm–Sidak post-hoc test (GraphPad Prism, 
GraphPad Software Inc., San Diego, CA). Significant differences were assessed using α = 0.05. 
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STATEMENT OF HYPOTHESIS 
Previously published studies have demonstrated that DA induces direct toxicity to 
proximal tubule epithelial cells (Huang et al., 2016; P. A. Peng et al., 2015). The purpose of my 
dissertation was to investigate the initial mechanisms of toxicity at clinically relevant DA 
concentrations which could provide a foundation for future studies to explore potential methods 
to mitigate or prevent CI-AKI. In order to determine these mechanisms, the following 
hypotheses were tested: exposure to DA decreases mitochondrial and cell viability of HK-2 cells 
at clinically relevant concentrations; the mechanism of this toxicity is caused by calcium 
dysregulation, mitochondrial degeneration, and oxidative stress; decreasing intracellular calcium 
mitigates DA induced cytotoxicity (Figure 6).  
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Figure 6. Hypothesized sequence of events following exposure of HK-2 cells to DA.   
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CHAPTER 3: RADIOCONTRAST AGENT DIATRIZOIC ACID INDUCES 
MITOPHAGY AND OXIDATIVE STRESS VIA CALCIUM DYSREGULATION 
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ABSTRACT 
 Contrast-Induced Acute Kidney Injury (CI-AKI) is the third most common cause of 
hospital associated kidney damage. Potential mechanisms of CI-AKI may involve diminished 
renal hemodynamics, inflammatory responses, and direct cytotoxicity. The hypothesis for this 
study is that diatrizoic acid (DA) induces direct cytotoxicity to human proximal tubule (HK-2) 
cells via calcium dysregulation, mitochondrial dysfunction, and oxidative stress. HK-2 cells were 
exposed to 0-30 mg I/mL DA or vehicle for 2-24 h. MTT conversion and trypan blue exclusion 
indicated a decrease in mitochondrial and cell viability within 2 and 24 h, respectively. 
Mitochondrial dysfunction was apparent within 8 h post exposure to 15 mg I/mL DA as shown 
by cell mito and glycolysis stress tests. Mitophagy was increased at 8 h by 15 mg I/mL DA as 
confirmed by elevated LC3BII/I expression ratio. HK-2 cells pretreated with calcium level 
modulators BAPTA-AM, EGTA, or 2-aminophenyl borinate abrogated DA-induced 
mitochondrial damage. DA increased oxidative stress biomarkers of protein carbonylation and 4-
hydroxynonenol (4-HNE) adduct formation. Caspase 3 and 12 activation was induced by DA 
compared to vehicle at 24 h. These studies indicate that clinically relevant concentrations of DA 
impair HK-2 cells by dysregulating calcium, inducing mitochondrial turnover and oxidative 
stress, and activating apoptosis.    
INTRODUCTION 
The use of iodinated radiocontrast media (RCM) to visualize internal structures during 
diagnostic procedures has increased exponentially since their first use in 1928. Exposure to RCM 
may lead to contrast-induced acute kidney injury (CI-AKI) which occurs in up to 30% of patients 
and is the third leading cause of iatrogenic acute renal failure accounting for 10-25% of all AKI 
cases (Fahling, Seeliger, Patzak, & Persson, 2017). Following X-ray based imaging procedures 
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such as percutaneous coronary intervention and cardiac angiography, renal dysfunction can range 
from non-symptomatic increases in serum creatinine (SCr) to severe and permanent renal 
damage resulting in the need for dialysis (Brown et al., 2016). The renal pathogenesis of CI-AKI 
is complex and not completely understood. Intravenous administration of RCM induces transient 
vasodilation of renal vasculature followed by severe, sustained vasoconstriction resulting in 
decreased oxygen supply and oxidative damage to the outer renal medulla (Z. Z. Liu et al., 2012; 
Persson et al., 2005). Aside from the renal ischemia, exposure to RCM has been shown to be 
directly toxic to renal parenchyma (Huang et al., 2016; Itoh et al., 2006; Jeong et al., 2018); 
however, the exact mechanisms of direct cytotoxicity have not been fully elucidated.  
Numerous studies using very high concentrations of RCM have been performed to 
evaluate direct toxicity of RCM within the proximal tubule (PT). Commonly reported responses 
to the interaction between very high concentrations RCM and the PT in vitro are vacuolization of 
the PT cells, increased production of ROS and induction of oxidative stress, mitochondrial 
dysfunction and the ensuing decline in ATP production and energy failure, activation of the 
unfolded protein response (UPR) and endoplasmic reticulum (ER) stress, and alterations in 
activity of stress kinases (Andersen et al., 1994; Andersen et al., 1995; Michael et al., 2014; 
Tervahartiala et al., 1997; Tervahartiala et al., 1991). Although there has been substantial 
knowledge obtained from these studies, the initial source of cellular damage remains elusive. 
This may be, in part, due to the clear majority of mechanistic studies using concentrations of 
RCM far higher than what PT cells experience in the healthy kidney. Studies commonly use 100-
200 mg I/mL RCM in vitro, equating to approximately 5-100 times concentrations found in 
circulating plasma (Ho, Nelson, & Delong, 2007; Thomsen & Morcos, 2000). It is possible that 
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exposing cells to concentrations of RCM of this magnitude are inducing changes in cellular 
homeostasis that would not occur at clinically relevant concentrations of RCM. 
The purpose of this study was to explore the various mechanisms of toxicity associated 
with the first generation RCM diatrizoic acid (DA) in a human kidney (HK-2) cell line. This 
model was chosen as these cells are adult, non-cancerous, immortalized human epithelial cells 
that maintain biochemical properties and activities similar to in vivo proximal tubule cells 
(Gunness et al., 2010; Paolicchi et al., 2003; Ryan et al., 1994). Additionally, HK-2 cells 
maintain organic ion transporters (OAT) 1 and 3, which have been reported to transport DA into 
proximal tubule cells (Mudge et al., 1971). The present study was undertaken to demonstrate that 
exposure of HK-2 cells to clinically relevant DA concentrations induce mitochondrial 
dysfunction, cytokine release and downstream activity, activate the UPR and ER stress, induce 
oxidative stress. This study also determines the role of calcium homeostasis in RCM-induced PT 
cytotoxicity. 
METHODS 
Chemicals and Reagents 
DA (S4506-50G), MTT (M2128-10G, and SOD activity kits (19160) were purchased 
from Sigma Aldrich (St. Louis, MO) and were used for all studies. The vehicle used for cell 
treatments was phosphate buffered saline (PBS) purchased from Fisher Scientific (Gibco, 
Pittsburg, PA, Item No. 14175-095). All other chemicals were of the highest quality and 
procured from Sigma Aldrich or Fisher Scientific Inc. Antibodies were purchased as indicated in 
the sections below. The OxyBlot™ Protein Oxidation Detection Kit was purchased from EMD 
Millipore (Burlington, MA, Item No. S7150). 
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Cell Line and Diatrizoic Acid (DA) Treatment 
Non-cancerous human immortalized kidney epithelial cells (HK-2) were purchased from 
the American Type Culture Collection (ATCC, Manassas, VA, Item No. CRL-2190) and were 
cultured according to ATCC guidelines. Cells were grown in keratinocyte-free media with added 
bovine pituitary extract (50 μg/mL) and recombinant epithelial growth factor (5 ng/mL) 
purchased from Fisher Scientific (Gibco, Carlsbad, CA, Item No. 17005-042). Cells were grown 
in a warm, humidified incubator set to 37°C with 5% CO2. HK-2 cells were plated into six-well 
cell culture plates (Corning, Sigma Aldrich Item No. CLS3516) at a cellular density of 750,000 
cells/mL and allowed to grow for 48 hr. Media was subsequently replaced and cells were treated 
with a final concentration of 0, 2, 5, 10, 15, 18, 23, 28, or 30 mg I/mL DA for 2, 8, or 24 hr prior 
to cell lysate collection. Vehicle control was an equal volume of PBS. Following the treatment 
period, media was removed via aspiration and cells were collected using Trypsin-EDTA (0.25%) 
(Gibco, Carlsbad, CA, Item No. 25200-072) for sample analysis.  
Mitochondrial and Cell Viability 
HK-2 cells were plated into 96-well cell culture plates (Cyto One Scientific, Ocala, FL, 
Item No. CC7682-7596) at a cellular density of 37,500 cells/mL and allowed to grow for 48 hr. 
Following the equilibration period, media was replaced, and cells were treated with a final 
concentration of 0, 2, 5, 10, 15, 18, 23, 28, or 30 mg I/mL DA for 2, 8, or 24 hr. Vehicle control 
was an equal volume of PBS. Mitochondrial viability was assessed using the MTT assay 
(Humphrey, Cole, Pendergrass, & Kiningham, 2005). The MTT assay relies on the conversion of 
tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma 
Aldrich, Item No. M5655-5X1G) to formazan by mitochondrial oxidoreductases.  
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Trypan blue exclusion was used as a confirmation that the DA mediated decline in MTT 
reduction was due to a decrease in mitochondrial viability and not an interaction between DA 
and mitochondrial reductase enzymes. The trypan blue exclusion assay was run using the 
Countess II FL cell counter (Thermo Fisher Scientific Inc.) An aliquot of collected cells were 
diluted 1:1 with 40% w/v trypan blue solution (Sigma Aldrich, Item No. T6146). The solution 
was lightly mixed via pipetting and a 10 μL aliquot was transferred to the Cell Countess II FL 
reusable glass slide prior to inserting the slide into the instruments sample port. The Cell 
Countess II FL measures total cells, living cells, and dead cells as a measure of overall cell 
viability.  
Mitochondrial Isolation 
Mitochondria were isolated from HK-2 cells collected with trypsin-EDTA using a 
Mitochondrial Isolation Kit for Cultured Cells (Thermo Scientific, Item No. 89874) and 
differential centrifugation. Mitochondria were isolated according to the manufacturer’s 
directions, with the exception of added protease inhibitor (Thermo Scientific, Item No. 78430) to 
prevent proteolytic degradation during isolation. Briefly, cells were centrifuged at 2000xg for 10 
min at 4°C and resuspended in 800 μL of Reagent A with added protease inhibitor (10 μL/mL). 
Samples were vortexed for five sec at maximum speed and then incubated on ice for 5 min. 
Following addition of 10 μL of Reagent B, samples were incubated on ice and vortexed for 5 sec 
at maximum speed every min for 10 min. Next, 800 μL of Reagent C with added protease 
inhibitor (10 μL/mL) was added, inverted multiple times to mix, and the samples were 
centrifuged at 700xg for 20 min at 4°C. The supernatant was transferred to new microcentrifuge 
tubes and centrifuged at 12,000xg for 15 min at 4°C. The supernatant (cytosolic fraction) was 
transferred to a new microcentrifuge tube and the pellet (mitochondrial fraction) was 
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resuspended in 100 μL cell lysis buffer. The cellular and mitochondrial fractions were then 
placed in a -80°C freezer prior to protein quantification via Bradford assay.  
Oxyblot and Western Blot 
Western blot analysis was conducted to assess the expression of glucose-regulated 
protein (GRP78), C/EPB homologous protein (CHOP), 4-hydroxynonenal (4-HNE), manganese 
superoxide dismutase (MnSOD), NADPH oxidase 4 (NOX4), tumor necrosis factor-α (TNF-α), 
cytochrome c, caspase 3, caspase 4, and caspase 12. Protein concentration was determined using 
the Bradford assay (Bradford, 1976). An aliquot of sample containing 40 μg of protein were 
placed in microcentrifuge tubes and denatured by placing in boiling water for 5 min followed by 
separation on a 12.5% polyacrylamide gel via electrophoresis and transferred onto a 0.45 µM 
nitrocellulose membrane (Bio-Rad, Hercules, CA, Item No. 1620115). Successful transfer and 
protein loading were verified using MemCode Reversible Protein Stain Kit (Pierce 
Biotechnology, Rockford, IL, Item No. PI-24580). Membranes were blocked at room 
temperature using 5% w/v milk/TBST solution (10 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-
20; pH 8.0), 1% Bovine Serum Albumin (BSA)/TBST, or 5% BSA/TBST solution for 1 hr. 
Membranes were next incubated with continual shaking overnight at 4°C with primary 
antibodies: GRP78 (1:1000 dilution, Abcam Inc; Cambridge, MA, Item No. ab21685), CHOP 
(1:1000, Cell Signaling Technology; Danvers, MA, Item No 5554), MnSOD (1:5000,  Abcam 
Inc; Cambridge, MA, Item No. ab13533), TNFα (1:1000, Abcam Inc; Cambridge, MA, Item No. 
ab66579), NOX4 (1:1000 Abcam Inc; Cambridge, MA, Item No. ab60940), LC3B (1:1000, 
Abcam Inc; Cambridge, MA, Item No. ab48394), 4-HNE (1:1000 dilution, Calbiochem; Merck, 
Darmstadt, Germany, Item No. 393207) cytochrome c (1:1000, Santa Cruz Biotechnology, Santa 
Cruz, CA, Item No. sc-7159), caspase 3 (1:1000, Cell Signaling Technology; Danvers, MA, Item 
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No. 9662), caspase 4 (1:1000, Cell Signaling Technology; Danvers, MA, Item No. 4450), and 
caspase 12 (1:1000, Cell Signaling Technology; Danvers, MA, Item No. 2202) in blocking 
solution. The membranes were washed three times with TBST or PBST for 10 min each 
followed by incubation with goat anti-rabbit HRP-linked secondary antibodies diluted to 1:2000 
in blocking solution for 1.0 to 1.5 hr. Membranes were washed again with TBST or PBST and 
then developed using Amersham ECL Western Blotting Detection Agent (GE Healthcare Life 
Sciences, Marlborough, MA, Item No. RPN2232). A BioRad chemic-doc system was used to 
capture the gel image and used for densitometry analysis (version 4.0.1, Catalog No. 170-9690, 
BioRad, Hercules, CA). 
Aside from 4-HNE protein adduct formation, protein carbonylation is also a marker of 
oxidative stress. The accumulation of carbonyl groups introduced into cellular proteins was 
measured using the Oxyblot Protein Oxidation Detection Kit (EMD Millipore, Burlington, MA, 
Item No. S7150). A 15 µg aliquot of sample was derivatized as previously described (Terneus et 
al., 2007). Protein carbonyl moieties on cellular proteins generated by oxidative stress are 
derivatized in the presence of 2,4-dinitrophenylhydrazine (DNPH) to stable 2,4-
dinitrophenylhydrazone groups. The 2,4-dinitrophenylhydrazone groups are recognized by the 
primary antibody (1:150 dilution in 1% BSA/PBST). A Bio-Rad chemi-doc system was used to 
capture the gel image and used for densitometry analysis (version 4.0.1, Bio-Rad, Hercules, CA, 
Catalog No. 170-9690). 
Seahorse XF Assays 
The Agilent Seahorse XFe analyzer allows for real-time measurements of cellular 
metabolic function in cultured cells. Oxygen Consumption Rate (OCR) and Extracellular 
Acidification Rate (ECAR) are measured to interrogate key cellular functions such as 
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mitochondrial respiration and glycolysis. Mitochondrial function and glycolysis were measured 
using Agilent cell mito stress tests, cell glycolysis stress tests, mito fuel flex tests, and real-time 
ATP rate assays following optimization of cell number per well. 
HK-2 cells were cultured in XFe Culture Miniplates (175,000 cells/mL) (Agilent 
Technologies, Item No. 101085-004) and allowed to grow for 48 hr followed by treatment with 
vehicle or 5, 15, 18, 23, 28, or 30 mg I/mL DA. Prior to the assay, cells were washed with assay 
media (Agilent Technologies, Item No. 103575-100) supplemented with 1 mM glucose (Agilent 
Technologies, Item No. 103577-100), 1 mM pyruvate (Agilent Technologies, Item No. 103578-
100), and 2 mM glutamine (Agilent Technologies, Santa Clara, CA, Item No. 103579-100) and 
equilibrated in 175 or 180 μL pre-warmed assay media at 37°C with no CO2 for 45 min.  
TNFα in Cell Media and Cell Lysate 
TNF-alpha is expressed on the surface of renal proximal tubular cells and is activated as 
part of the inflammatory response within the kidney. TNFα concentrations were measured in cell 
culture media using an ELISA assay kit (Abcam, Cambridge, MA, USA, Item No. ab181421) 
per the manufacturer’s instructions. Briefly, 50 μL of collected media and a capture/detector 
antibody cocktail were added to precoated wells and incubated for 1 hr, shaking at 400 rpm. 
Following the immunocapture incubation period, the wells were washed and 3,3t,5,5t-
tetramethylbenzidine (TMB) substrate was added, producing a color change based on the amount 
of bound TNFα, which was then read at 450 nm. The TNFα concentration was determined using 
a standard curve. TNFα expression in DA treated cell lysate was determined using Western blot 
as described above. Each lane was loaded with 40 μg of protein; membranes were probed using a 
rabbit-polyclonal HRP-linked antibody for TNFα diluted to 1:1000 in 5% BSA/TBST (Abcam, 
Item No. ab66579). TNFα was normalized to protein and compared relative to control. 
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SOD Activity Assay 
SOD activity was determined using a Fluka designed spectrophotometric kit purchased 
from Sigma (St. Louis, MO, Item No. 19160). Cu/Zn-SOD was inhibited by incubating the 
sample (40 µg/µL cell lysate) at room temperature with sodium diethyldithiocarbamate (DDTC) 
at a final concentration of 25 mM. The difference between total SOD and MnSOD activity was 
calculated as a measure of Cu/ZnSOD activity. The assay was completed according to 
manufacturer’s recommendations. 
Calcium Assays 
 MTT assays and cellular fractions were isolated for protein expression following 
pretreatment with various calcium modulators to analyze the influence of intracellular calcium 
concentration on mitochondrial viability, mitophagy, and apoptosis. HK-2 cells were pretreated 
with 10 µM of the intracellular calcium chelator, 1, 2-bis (o-aminophenoxy) ethane-N,N,N’,N’-
tetra-acetic acid (BAPTA-AM) (Sigma-Aldrich, Item No. A1076-25MG), 1 mM of extracellular 
calcium chelator, ethyleneglycol-bis(β-aminoethyl)-N,N,N’,N’-tetra-acetic acid (EGTA) (Sigma-
Aldrich, Item No. E3889-25G), 10 µM of the inositol trisphosphate receptor antagonist, 2-
aminoethoxydiphenyl borinate (2-APB) (Sigma-Aldrich, Item No. D9754), or 10 µM of the 
calpain inhibitor, calpeptin (Sigma-Aldrich, Item No. C8999), for 45 min prior to the addition of 
DA. HK-2 cells were then incubated for 24 hr with varying concentrations of DA as described 
above. The calpain activity assay kit was purchased from AnaSpec Inc. (Fremont, CA, Item No. 
AS-72149) was used to determine the role of calcium in mitophagy and apoptosis. The calpain 
activity assay was performed in a 96-well plate according to manufacturer’s instructions.  
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Statistical Analysis 
Values represent mean ± SEM with at least 3 independent experiments conducted. 
Differences between groups were determined with a one-way ANOVA followed by a Holm–
Sidak post-hoc test with α < 0.05 (GraphPad Prism, GraphPad Software Inc., San Diego, CA). 
RESULTS 
DA Effects on Mitochondrial and Cell Viability 
Conversion of MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), to 
its insoluble formazan dye counterpart was used as an indicator of mitochondrial viability. DA 
exposure induced concentration and time dependent changes in MTT (Figure 7). Exposure to DA 
substantially reduced mitochondrial viability within 2 hr (p < 0.001) beginning with the 15 mg 
I/mL DA when compared to vehicle control. MTT values were diminished at all DA 
concentrations at 8 hr and 24 hr (p < 0.001) when compared to vehicle control (Figure 7). A 
concentration-dependent decrease in mitochondrial viability was evident at 8 hr and 24 hr when 
compared to other treatment groups (p < 0.05) (Figure 7). A time-dependent decrease in 
mitochondrial viability was also evident between the 2 hr and 24 hr treatment groups at 23-30 
mg I/mL (p < 0.01) (Figure 7).  
Trypan blue exclusion was used as an indicator of cell viability, as well as confirmation 
that the DA mediated decline in MTT reduction was not due to a decrease in the overall number 
of viable cells. Unlike the MTT assay, there was no significant decrease in cell viability until 24 
hr exposure to concentrations of 23 mg I/mL DA or higher (p < 0.05) (Figure 8). DA final 
concentrations of 28 and 30 mg I/mL showed an additional decline in cell viability at 24 hr when 
compared to other treatment groups (p < 0.05) (Figure 8). A time-dependent decrease in cell 
viability was also evident when compared to other time points (p < 0.01) (Figure 8). 
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Concentrations of DA of 15 mg I/mL and 23 mg I/mL decreased the conversion of MTT to 
formazan within 2 hr and trypan blue exclusion within 24 hr of DA exposure when compared to 
vehicle control, respectively, suggesting that our model is appropriate to explore the cellular 
mechanisms of DA-induced cytotoxicity in HK-2 cells.  
 
Figure 7. Diatrizoic acid cytotoxic effects on mitochondrial viability in HK-2 cells using 
MTT. DA diminished mitochondrial viability at 2 hr (A), 8 hr (B), and 24 hr (C). Different 
superscripts (a-f) indicate a statistical difference between groups across all time points. Statistical 
difference between time and concentration of each group was determined using Holm-sidak post-
hoc test following two-way ANOVA. Values represent mean ± SEM for three independent 
experiments of at least 4 biological replicants.  
 
Figure 8. Diatrizoic acid cytotoxic effects on cell viability in HK-2 cells using Trypan Blue 
Exclusion. DA diminished cell viability at 24 hr (C) but not at 2 hr (A) or 8 hr (B). Different 
superscripts (a, b, c) indicate a statistical difference between groups across all time points. 
Statistical difference between time and concentration of each group was determined using Holm-
sidak post-hoc test following two-way ANOVA. Values represent mean ± SEM for three 
independent experiments of at least 4 biological replicants.  
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DA Effects on Mitochondrial Function and Energy Utilization 
Mitochondrial function following exposure to DA was assessed using an Agilent 
Seahorse XFe instrument. In an attempt to more accurately understand the effects of DA on 
mitochondrial function, various XFe assays were utilized including: cell mito stress test, cell 
glycolysis stress test, mito fuel flex test, and real-time ATP rate assay. In the cell mitochondrial 
stress test, oxygen consumption rate (OCR) following serial injection of various probes is used 
as an indicator of mitochondrial function. Oligomycin, an ATP synthase inhibitor, probes for 
ATP linked oxygen consumption; FCCP, an oxidative phosphorylation uncoupling agent, 
induces maximum oxygen consumption and the resultant OCR can be used to calculate spare 
respiratory capacity. The final injection, a mixture of rotenone and antimycin-A, inhibits 
complex I and complex III resulting in complete inhibition of mitochondrial respiration and 
determination of the non-mitochondrial oxygen consumption.   
Statistically significant decreases in basal OCR, maximal OCR, spare respiratory 
capacity, and ATP production were evident at 8 and 24 hr (Figure 9). OCR was decreased at 18 
mg I/mL for basal OCR (p < 0.05), 15 mg I/mL for maximal OCR and spare respiratory capacity 
(p < 0.01), and 23 mg I/mL for ATP production (p < 0.05) when compared to vehicle control at 8 
hr; however, OCR linked to proton leak and non-mitochondrial oxygen consumption did not 
change (Figure 9). Basal OCR, maximal OCR, spare respiratory capacity, and ATP production 
were all significantly decreased at 15 mg I/mL (p < 0.001) within 24 hr when compared to 
vehicle control (Figure 9). Similar to the 8 hr timepoint, there was no change in non-
mitochondrial oxygen consumption, although, there was an increase in OCR linked to proton 
leak at 30 mg I/mL (p < 0.05) when compared to vehicle control at 24 hr (Figure 9). 
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Figure 9. Diatrizoic acid effects on various parameters of mitochondrial respiration in HK-
2 cells. DA diminished key parameters of mitochondrial respiration following 8 hr (A) and 24 hr 
(B) exposure. Representative time course profile of OCR of a Seahorse cell mito stress test 
following exposure to DA for 8Hr (C) and 24 hr (D). Statistical difference from 0 mg I/mL DA 
depicted by an asterisk (* p < 0.05, ** p < 0.01, *** p < 0.001). Values represent mean ± SEM 
for three independent experiments of at least four biological replicants 
 
The cell glycolysis stress test utilizes extracellular acidification rate (ECAR) as an 
indicator of various parameters of glycolysis. HK-2 cells were starved of glucose and pyruvate 
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for 40 min prior to glucose saturation and measurement of basal glycolysis. The ATP synthase 
inhibitor oligomycin was then injected to drive glycolysis to maximum capacity from which 
glycolytic capacity and glycolytic reserve can be calculated. ECAR linked to non-glycolytic 
acidification is determined by the addition of the hexokinase inhibitor, 2-deoxyglucose. Whereas 
decreases in OCR are evident at 15 mg I/mL at both 8 and 24 hr, statistically significant 
decreases in glycolysis and glycolytic capacity as shown by ECAR were not apparent until 28 
mg I/mL at 8 hr (p < 0.05) and 23 mg I/mL at 24 hr (p < 0.05) (Figure 10). Glycolytic reserve 
and non-glycolytic acidification were unchanged for all concentrations at both time points 
(Figure 10). 
 
Figure 10. Diatrizoic acid effects on various parameters of glycolysis in HK-2 cells. DA 
diminished key parameters of glycolysis following 8 hr (A) and 24 hr (B) exposure. 
Representative time course profile of ECAR of a Seahorse cell glycolytic stress test following 
exposure to DA for 8 hr (C) and 24 hr (D). Statistical difference from 0 mg I/mL DA depicted by 
an asterisk (* p < 0.05, ** p < 0.01). Values represent mean ± SEM for three independent 
experiments of at least four biological replicants. 
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The initial studies examining mitochondrial function indicated DA impaired 
mitochondrial function prior to alterations in cell viability (Figure 8). Additional independent 
studies were conducted to probe alterations in mitochondrial function and energy production. 
The real-time ATP rate assay was used to evaluate DA changes in mitochondrial and glycolytic 
pathway production of ATP. The real-time ATP assays utilize serial injections of oligomycin and 
rotenone/antimycin-A to determine ATP production within the cell. OCR, ECAR, and proton 
efflux rate (PER) measurements are used to calculate total ATP production, glycolytic ATP 
production, and mitochondrial ATP production. Exposure to DA for 24 hr induced a significant 
decrease in total and mitochondrial ATP production at 18 mg I/mL (p < 0.05) but the slight 
decrease in glycolytic ATP production was not significant (Figure 11). The findings suggest that 
the decline in total ATP production, therefore, can be attributed to the decrease in mitochondrial 
ATP production. 
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Figure 11. Diatrizoic acid effects on mitochondrial, glycolytic, and total ATP production. 
DA diminished ATP production linked to mitochondrial respiration (A) and total ATP 
production (C) but not glycolytic ATP production (B) following 24 hr exposure. Representative 
graph of ATP production of the real-time ATP rate assay following exposure to DA for 24 hr 
(D). Statistical difference from 0 mg I/mL DA depicted by an asterisk (* p < 0.05, *** p < 
0.001). Values represent mean ± SEM for three independent experiments of at least four 
biological replicants. 
 
The mito fuel flex test measures OCR following inhibition of the three major 
mitochondrial fuel sources (glucose, glutamine, and fatty acid oxidation) to determine the 
mitochondrial dependency and flexibility on each fuel source. The mitochondrial dependency on 
a specific fuel source is determined by first injecting an inhibitor of the pathway in question 
followed by inhibition of the other two pathways. The flexibility of the mitochondria to adjust to 
changes in fuel sources is calculated by subtracting the dependency of a fuel source from the 
mitochondrial capacity of that fuel source. Capacity is determined by first inhibiting the other 
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fuel pathways followed by the pathway in question. In response to exposure to DA for 8 hr, there 
was no significant change in the dependency of glutamine, glucose, or fatty acid oxidation 
(Figure 12). The flexibility to glutamine and glucose oxidation was unchanged as well (Figure 
12). These results suggest that DA does not inflict damage to the fuel transport or oxidation 
machinery within the mitochondria.  
 
 
Figure 12. Diatrizoic acid effects on mitochondrial fuel oxidation in HK-2 cells. DA does not 
affect mitochondrially-linked oxidation of glucose (A), glutamine (B), and fatty acids (C) in 
response to 8 hr exposure. Values represent mean ± SEM for three independent experiments of at 
least four biological replicants. 
 
DA Effects on Mitophagy  
 A decrease in mitochondrial function in the absence of damage to mitochondrial fuel 
oxidation can be explained by other means. The global decrease in OCR seen in response to DA 
could be attributed to a decrease in the total number of active mitochondria. To evaluate the role 
of exposure to DA on mitochondrial turnover, the expression of microtubule-associated proteins 
1A/1B light chain 3B I and II (LC3BI and II) was evaluated. A statistically significant decrease 
in LC3BI was evident in response to exposure of HK-2 cells to DA within 8 hr at 18 mg I/mL (p 
< 0.05) and at 15 mg I/mL within 24 hr (p < 0.05) (Figure 13, Figure 14). An increase in LC3BII 
expression was not apparent within 8 hr of exposure to DA (Figure 13), however, an increase in 
LC3BII expression did increase to significance within 24 hr (p < 0.01) (Figure 14). The relative 
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ratio of LC3BII/I was significantly increased (p < 0.05, p < 0.01) at both time points (Figure 13, 
Figure 14). These findings suggest that the decrease in OCR observed in the cell mito stress 
could be due to mitophagy and not damage to the electron transport chain or transport 
machinery. This conclusion is supported by the results of the mito fuel flex test.  
 
Figure 13. Diatrizoic acid effects on LC3B expression in HK-2 cells following 8 hr exposure. 
DA induces mitophagy following 8 hr exposure. Representative blots and cumulative 
densitometry included for LC3BI (A), LC3BII (B) exposure, and LC3BII/LC3B I ratio (C) 
following 8 hr exposure to DA. Representative blot with Memcode Reversible stain for 40 µg 
loaded protein and cumulative protein densitometry depicted for 8 hr (D) exposure. Statistical 
difference from 0 mg I/mL diatrizoic acid depicted by an asterisk (* p < 0.05, ** p < 0.01, *** p 
< 0.001). Values represent mean ± SEM for three independent experiments of two biological 
replicants. 
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Figure 14. Diatrizoic acid effects on LC3B expression in HK-2 cells following 24 hr 
exposure. DA induces mitophagy following 24 hr exposure. Representative blots and cumulative 
densitometry included for LC3BI (A), LC3BII (B) exposure, and LC3BII/LC3BI ratio (C) 
following 24 hr exposure to DA. Representative blot with Memcode Reversible stain for 40 µg 
loaded protein and cumulative protein densitometry depicted for 24 hr (D) exposure. Statistical 
difference from 0 mg I/mL diatrizoic acid depicted by an asterisk (* p < 0.05, ** p < 0.01, *** p 
< 0.001). Values represent mean ± SEM for three independent experiments of two biological 
replicants. 
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DA Effects on Endoplasmic Reticulum Stress 
Potential mechanisms for DA cytotoxicity to the PT may be mediated by alterations in 
cell repair and protein folding. To evaluate the role of DA exposure and the induction of the 
unfolded protein response (UPR) and ER stress, the expression of GRP78, CHOP, and the ER 
stress specific caspase, caspase-12, were measured via Western blot. No change in GRP78 
expression was evident following exposure to DA for 2, 8, and 24 hr (Figure 15). Expression of 
CHOP, which is increased in response to prolonged activation of the UPR, was not apparent 
following 8 or 24 hr exposure to DA (Figure 16). Although activation of the UPR and 
subsequent induction of ER stress was not evident by GRP78 or CHOP expression, there was an 
increase in caspase 12 at 24 hr (Figure 23) relative to vehicle control (p < 0.05). These results 
suggest that UPR and ER stress do not play a role in DA-induced cytotoxicity and caspase 12 
activation is initiated by another pathway.  
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Figure 15. Diatrizoic acid effects on GRP78 expression in HK-2 cells. DA does not activate 
the UPR. Representative blots and cumulative densitometry included for GRP78 expression 
following 2 hr (A), 8 hr (B), and 24 hr (C) exposure to DA. Representative blot with Memcode 
Reversible stain for 40 µg loaded protein and cumulative protein densitometry depicted for 2 hr 
(D), 8 hr (E), and 24 hr (F) exposure. Values represent mean ± SEM for three independent 
experiments of two biological replicants. 
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Figure 16. Diatrizoic acid effects on CHOP expression in HK-2 cells.  DA does not induce ER 
stress. Representative blots and cumulative densitometry included for CHOP expression 
following 24 hr (A) exposure to DA. Representative blot with Memcode Reversible stain for 40 
µg loaded protein and cumulative protein densitometry depicted for 24 hr (B) exposure. Positive 
control for CHOP expression was thapsigargin, abbreviated THAP. Values represent mean ± 
SEM for three independent experiments of two biological replicants. 
 
DA Effects on Oxidative Stress 
To evaluate the role of DA exposure and the activation of oxidative stress, protein 
carbonylation and 4-hydroxynonenal (4-HNE) protein adduct formation were measured via 
Oxyblot and Western blot, respectively. DA increased oxidative stress as shown by Oxyblot 
analysis at 24 hr relative to vehicle control in groups treated with 18 mg I/mL DA (p < 0.05) 
(Figure 17). Protein carbonylation was not increased relative to control at 8 hr or at lower 
concentrations at 24 hr (Figure 17). DA increased oxidative stress as shown by 4-HNE adduct 
formation at 24 hr relative to vehicle control in groups treated with 18 mg I/mL DA (p < 0.05) 
(Figure 18). 4-HNE protein adduct formation was not increased relative to control at 8 hr or at 
lower DA concentrations at 24 hr (Figure 18). 
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Figure 17. Diatrizoic acid effects on protein carbonylation in HK-2 cells. An increase in 
protein carbonylation was evident in cell lysate following 24 hr (C) in 18 mg I/mL to 30 mg 
I/mL DA. Representative blots and cumulative densitometry included for 8 hr (A) and 24 hr (C) 
exposure to diatrizoic acid. Representative blot with Memcode Reversible stain for 15 µg loaded 
protein and cumulative protein densitometry depicted for 8 hr (B) and 24 hr (D) exposure. 
Statistical difference from 0 mg I/mL diatrizoic acid depicted by an asterisk (* p < 0.05, ** p < 
0.01, *** p < 0.001). Values represent mean ± SEM for three independent experiments of two 
biological replicants. 
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Figure 18. Diatrizoic acid effects on 4-HNE adduct formation in HK-2 cells. An increase in 
protein adduct formation was evident in cell lysate following 24 hr exposure (C) in 18 mg I/mL 
to 30 mg I/mL DA. Representative blots and cumulative densitometry included for 8 hr (A) and 
24 hr (C) exposure. Representative blot with Memcode Reversible stain for 40 µg loaded protein 
and cumulative protein densitometry depicted for 8 hr (B) and 24 hr (D) exposure. Statistical 
difference from 0 mg I/mL diatrizoic acid depicted by an asterisk (* p < 0.05). Values represent 
mean ± SEM for three independent experiments of two biological replicants. 
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Initially, MnSOD expression was measured to determine the effect of DA exposure on 
antioxidant systems within the mitochondria. In response to DA exposure for 24 hr, there was no 
noticeable change in MnSOD expression (Figure 19). Due to the fact that levels of expression do 
not necessarily indicate activity of an enzyme, MnSOD, Cu/ZnSOD, and Total SOD activity 
were measured to evaluate the effects of DA on cellular antioxidant systems. Total SOD activity 
was decreased at 24 hr relative to vehicle control in groups treated with 28 and 30 mg I/mL (p < 
0.05) (Figure 19). MnSOD activity was unchanged in response to exposure to DA at 24 hr 
(Figure 19), while Cu/ZnSOD activity was significantly reduced in response to 23 mg I/mL DA 
(p < 0.05) relative to vehicle control at 24 hr exposure (Figure 19). Protein carbonylation and 4-
HNE adduction were measured in cytosolic and mitochondrial fractions to determine if MnSOD 
activity within the mitochondria is protecting HK-2 mitochondria from DA-induced ROS 
generation. Following exposure to 30 mg I/mL DA for 24, protein carbonylation and 4-HNE 
protein adduction is significantly increased in response to control within the cytosolic fraction 
but there was no change in either biomarker of oxidative stress in the mitochondrial fraction 
(Figure 20).  
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Figure 19. Diatrizoic acid effects on superoxide dismutase expression and activity in cellular 
fractions of HK-2 cells. A decrease in total SOD activity was evident in groups treated with 28 
and 30 mg I/mL at 24 hr (A). No significant change in MnSOD activity was apparent following 
24 hr (B) exposure to DA. A decrease in Cu/Zn activity (C) was evident following 24 hr 
exposure to 23-30 mg I/ml. Exposure to DA did not induce a change in MnSOD expression (D). 
Representative blots and cumulative densitometry included for 24 hr (D) exposure. 
Representative blot with Memcode Reversible stain for 40 µg loaded protein and cumulative 
protein densitometry depicted for 24 hr (E) exposure. Statistical difference from 0 mg I/mL 
diatrizoic acid depicted by an asterisk (* p < 0.05, ** p < 0.01). Values represent mean ± SEM 
for three independent experiments of two biological replicants. 
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Figure 20. Diatrizoic acid effects on oxidative stress within cellular fractions of HK-2 cells. 
DA-induced oxidative stress takes place in the cytosol. Representative blot and cumulative 
densitometry for expression of Oxyblot (A) and 4-HNE protein adducts (C) in cytosolic and 
mitochondrial fractions following 24 hr exposure to DA. Representative blots of MemCode 
reversible staining for 15 and 40 µg protein loading and cumulative densitometry for Oxyblot 
(B) and 4-HNE (D). Asterisks (* p < 0.05) indicate statistical difference from vehicle control in 
cytosolic fraction. Values represent mean ± SEM for three independent experiments of two 
biological replicants. 
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To evaluate potential sources for ROS production, TNFα expression was measured in cell 
lysate and cell media via Western blot and ELISA, respectively. TNFα expression in cell lysate 
decreased at 24 hr relative to vehicle control in groups treated with 15 and 18 mg I/mL DA (p < 
0.01) as shown by Western blot (Figure 21). TNFα secretion into the media was increased at 24 
hr relative to vehicle control (p < 0.05) in groups treated with 15 and 18 mg I/mL as shown by 
ELISA (Figure 21). NADPH oxidase 4 (NOX4), a ROS generating enzyme linked to TNF-α, 
expression was also measured. NOX4 expression was unchanged in response to exposure to DA 
at 24 hr (Figure 21). Although it is apparent that DA exposure elicits an inflammatory response 
in HK-2 cells, activation of TNFα does not play a role in DA-induced oxidative stress at 
clinically relevant concentrations. Therefore, the source of ROS overproduction in response to 
DA is unclear.  
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Figure 21. Diatrizoic acid effects on TNFα and NOX4 expression in HK-2 cells. DA induces 
TNFα activation but does not affect downstream effectors. TNFα expression in cell lysate was 
decreased in response to 15 and 18 mg I/mL DA at 24 hr (A). An increase in TNFα leakage into 
the cell media was evident following 24 hr (C) in 15 and 18 mg I/mL DA. No significant change 
in NOX4 expression was apparent in cell lysate following 24 hr (D) exposure to DA. 
Representative blot with Memcode Reversible stain for 40 µg loaded protein and cumulative 
protein densitometry depicted for TNFα (B) and NOX4 (E) following 24 hr exposure. Statistical 
difference from 0 mg I/mL diatrizoic acid depicted by an asterisk (* p < 0.05). Values represent 
mean ± SEM for three independent experiments of two biological replicants. 
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DA Effects on Mitochondrial Membrane Leakage and Apoptosis Initiation  
 Alterations in mitochondrial membrane integrity were evident following exposure to DA 
for 24 hr. DA caused significant cytochrome c leakage from the mitochondrial inner membrane 
space into the cytosol relative to vehicle control (p < 0.05) and the expression of cytochrome c 
within mitochondrial fractions decreased at 30 mg I/mL relative to control (p < 0.05) as shown 
by Western blot (Figure 22). 
 
Figure 22. Diatrizoic acid effects on mitochondrial membrane integrity in HK-2 cells. DA 
diminished mitochondrial membrane integrity. Representative blot and cumulative densitometry 
for cytochrome c (A) in cytosolic and mitochondrial fractions following 24 hr exposure to DA. 
Representative blots of MemCode reversible staining for 40 µg protein loading and cumulative 
densitometry for cytochrome c (B). Asterisks (* p < 0.05, ** p 0<0.01) indicate statistical 
difference from vehicle control in cytosolic fraction. Octothorpe (# p < 0.05) indicate statistical 
difference from vehicle control in mitochondrial fraction. Values represent mean ± SEM for 
three independent experiments of two biological replicants. 
 
DA increased caspase 3 cleavage and caspase 12 expression relative to vehicle control at 
28 and 30 mg I/mL following 24 hr exposure (p < 0.05, p < 0.01) (Figure 23). Caspase 4 
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expression and cleavage was unchanged in response to exposure to DA for 24 hr suggesting that 
the efflux of TNFα into the media was not sufficient to induce activation of caspase 4 (Figure 
23). 
 
Figure 23. Diatrizoic acid effects on the expression of caspase 4, caspase 12, and caspase 3 
in HK-2 cells. DA induces apoptosis via caspase 3 and caspase 12 activation. Representative 
blot and cumulative densitometry for total caspase 4 (A), caspase 12 (B), and cleaved caspase 3 
(C) protein expression following 24 hr exposure to DA. Asterisks (* p < 0.05, ** p 0<0.01) 
indicate statistical difference from vehicle control. Representative blots of MemCode reversible 
staining for 40 µg protein loading and cumulative densitometry for caspase 4 (D), caspase 12 
(E), and cleaved caspase 3 (F). Values represent mean ± SEM for three independent experiments 
of two biological replicants. 
 
DA Effects on Calcium Homeostasis 
 Mitochondrial viability and calpain activity assays were utilized to determine the role of 
calcium homeostasis in DA-induced cytotoxicity. MTT assays were performed on HK-2 cells 
pretreated for 45 min with EGTA, BAPTA-AM, or 2-APB prior to exposure to clinically 
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relevant concentrations of DA ranging from 15 to 30 mg I/mL. The concentrations of EGTA or 
BAPTA-AM selected for these studies were not cytotoxic based on the results of the MTT assay. 
Higher concentrations of BAPTA-AM induced some alterations in the MTT assay and were 
omitted from any studies with DA. Pretreatment with BAPTA-AM completely protected against 
DA-induced cytotoxicity within 2, 8, and 24 hr as seen by MTT assays (Figure 24). Within 2 hr, 
neither EGTA or 2-APB showed any statistically significant protection, however, both showed 
partial protection within 8 hr at 30 mg I/mL (p < 0.05) when compared to the DA group (Figure 
24). EGTA and 2-APB provided partial protection from DA-induced cytotoxicity within 24 hr 
exposure to DA (p < 0.05) when compared to the DA group (Figure 24). Calpain activity assays 
were performed to determine the role of calcium dependent proteases in DA-induced apoptosis. 
HK-2 cells exposed to 30 mg I/mL for 24 hr experienced a two-fold increase in calpain activity 
(p < 0.05) compared to vehicle control (Figure 25). Pretreatment with 10 µM BAPTA-AM or 10 
µM calpeptin prior to DA exposure completely inhibited calpain activity (Figure 25).  
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Figure 24. Effects of EGTA, BAPTA-AM, or 2-APB pretreatment on mitochondrial 
viability in HK-2 cells. DA induced cytotoxicity is attenuated in response to calcium 
concentration modulators. BAPTA-AM offered protection from DA-induced cytotoxicity within 
2 hr (A), 8 hr (B), and 24 hr (C). EGTA and 2-APB provided partial protection from DA-induced 
cytotoxicity within 8 hr (B) and 24 hr (C). Different superscripts (a-d) indicate a statistical 
difference between groups. Values represent mean ± SEM for three independent experiments 
with at least 4 biological replicants. 
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Figure 25. Diatrizoic acid effects on calpain activity in HK-2 cells.  DA induced activation of 
calpain. HK-2 cells exposed to 30 mg I/mL DA for 24 hr demonstrated a two-fold increase in 
calpain activity. Pretreatment with either 10 µM BAPTA-AM (calcium chelator) or 10 µM 
calpeptin (Cal; calpain pathway inhibitor) completely abrogated DA-induced calpain activity. 
Different superscripts (a, b) indicate a statistical difference between groups. Values represent 
mean ± SEM for three independent experiments of two biological replicants. 
 
To investigate the role of DA-induced calcium dysregulation in mitophagy, oxidative 
stress, and apoptosis, protein expression of LC3BI and II, protein carbonylation, 4-HNE, and 
caspase 12 were measured via Western blots and Oxyblot. HK-2 cells pretreated with BAPTA-
AM completely abrogated the conversion of LC3BI to LC3BII (p < 0.05) induced by exposure to 
DA (Figure 26). Pretreatment with the calpain inhibitor partially inhibited the initiation of 
mitophagy (p < 0.05) indicating that calpain activation may play a role in mitochondrial turnover 
(Figure 26). Chelation of intracellular calcium or inhibition of calpain activation decreased 
protein carbonylation, however, not to a significant degree (Figure 27). However, DA-induced 4-
HNE adduct formation was completely abrogated (P < 0.05) in response to BAPTA-AM and 
calpeptin (Figure 27). Caspase 12 activation was also attenuated in response to BAPTA-AM and 
calpeptin (p < 0.05) (Figure 28) indicating that caspase 12 activity is not dependent on ER stress 
but can be activated in response to calpain activity. 
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Figure 26. Effects of BAPTA-AM or calpeptin pretreatment on LC3B expression in HK-2 
cells. Pretreating HK-2 cells with BAPTA-AM or calpeptin attenuated DA-induced conversion 
of LC3BI to LC3BII. Representative blots and cumulative densitometry included for LC3BI (A), 
LC3BII (B), and LC3BII/LC3B I ratio (C) following 24 hr exposure to DA. Representative blot 
with Memcode Reversible stain for 40 µg loaded protein and cumulative protein densitometry 
depicted for 8 hr (D) exposure. Positive control for LC3B conversion was FCCP. Different 
superscripts (a, b, c) indicate a statistical difference between groups. Values represent mean ± 
SEM for three independent experiments of two biological replicants. 
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Figure 27. Effects of BAPTA-AM or calpeptin pretreatment on oxidative stress in HK-2 
cells. Pretreatment with BAPTA-AM or calpeptin slightly decreased protein carbonylation and 
completely abrogated 4-HNE adduct formation. Representative blots and cumulative 
densitometry included for protein carbonylation (A) and 4-HNE adduct formation (B) following 
24 hr exposure to DA. Representative blot with Memcode Reversible stain for 15 µg and 40 µg 
loaded protein and cumulative protein densitometry depicted for protein carbonylation (C) and 4-
HNE adduct formation (D). Different superscripts (a, b) indicate a statistical difference between 
groups. Values represent mean ± SEM for three independent experiments of two biological 
replicants. 
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Figure 28. Effects of BAPTA-AM or calpeptin pretreatment on caspase 12 activity in HK-2 
cells. Pretreatment with BAPTA-AM or calpeptin abrogated caspase 12 activation. 
Representative blots and cumulative densitometry included for caspase 12 (A) following 24 hr 
exposure to DA. Representative blot with Memcode Reversible stain for 40 µg loaded protein 
and cumulative protein densitometry (B). Positive control for caspase 12 activation was 
thapsigargin. Different superscripts (a, b) indicate a statistical difference between groups. Values 
represent mean ± SEM for three independent experiments of two biological replicants. 
 
DISCUSSION 
The use of RCM in radiographic imaging procedures does not show any sign of slowing 
down. Over 75 million contrast-requiring procedures are performed every year worldwide, and 
since 2006, the number of CT scans has increased by over 800% (Bottinor, Polkampally, & 
Jovin, 2013; Brown et al., 2016). As patient life expectancy increases, the need for diagnostic 
procedures such as percutaneous coronary intervention (PCI) and cardiac catheterizations 
linearly increase as well (Sawhney & Fraser, 2017). Unfortunately, the combination of 
comorbidities that decrease renal function and exposure to RCM leads to CI-AKI resulting in 
increased length of hospital stay, cardiovascular events, end-stage renal disease, and all-cause 
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mortality (Brown et al., 2010; Chertow et al., 2005; James et al., 2013). RCM toxicity is 
associated with severe renal vasoconstriction, activation of multiple inflammatory pathways, and 
direct tubule damage. The combination of these humoral responses can induce renal injury 
ranging from non-symptomatic increases in SCr to extensive damage resulting in permanent 
kidney failure and the need for dialysis. Although the effects of RCM exposure have been well 
documented, the exact mechanisms of toxicity have not been fully elucidated. A vast number of 
clinical reports, observational studies, and in vivo studies have explored the incidence of CI-AKI 
following exposure to RCM, most finding significant risk; however, little is known about the 
initial sources of renal injury and direct cellular toxicity pertaining to RCM exposure. 
Discovering and understanding the mechanisms of toxicity is imperative for the development of 
an appropriate preventative measure or treatment option to mitigate CI-AKI.  
To determine the source of RCM induced cytotoxicity, in vitro models must be 
implemented to eliminate renal hemodynamic and inflammatory responses to RCM exposure. 
Various cell models have been utilized throughout the years including MDCK, LLC-PK1, HEK-
293, and NRK-E52, however, mechanistic studies require a model that can be translated directly 
to human physiology. Therefore, the human kidney cell model, HK-2, was chosen. In order to 
determine the initial mechanisms of cellular toxicity, the model in question must be exposed to 
concentrations of RCM that the kidney would experience in a clinical setting. On average, the 
adult human male, aged 19-95 years, has blood plasma volumes of 45.2 to 53 ml/kg body weight 
(Yiengst & Shock, 1962). An effective dose of an RCM for CT imaging such as coronary 
arteriography can range from 45 to 150mL. Therefore, for a 75kg adult male, blood plasma 
levels of RCM will range from 4 to 15 mg I/mL (Lusic & Grinstaff, 2013). These concentrations 
can effectively be doubled for larger patients and dosages can continue to increase until the 
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effective termination limit of 300mL of a 76% DA preparation or equivalent has been injected 
(Skucas, 1989). It is not uncommon for mechanistic studies to expose in vitro models to 
concentrations of RCM over 150 mg I/mL, which is up to twenty-five-fold greater than blood 
plasma levels. In this study, a wide range of DA concentrations (0, 2, 5, 10, 15, 18, 23, 28, and 
30 mg I/mL) were chosen to encompass what the kidney would experience following a modern 
imaging procedure. Although an extensive number of peer-reviewed studies indicate the roles of 
various pathways and propose multiple mechanisms of toxicity, the initial source of damage has 
yet to be identified at clinically relevant concentrations.  
Our study is the first to show that clinically relevant concentrations of DA induces 
cytotoxicity. MTT conversion was used as a measure of mitochondrial viability because the 
reduction of the yellow tetrazolium dye to its purple formazan counterpart is performed primarily 
by mitochondrial dehydrogenases (Rai et al., 2018). Mitochondrial viability was decreased in 
HK-2 cells within 2 hr at 15 mg I/mL and continued to decrease at 8 and 24 hr at 2 mg I/mL as 
shown by MTT to formazan conversion. It is important to mention that a decrease in MTT 
conversion does not necessarily demonstrate a decrease in the total number of viable cells and 
vice versa (Chung, Kim, & Kim, 2015). Hence, trypan blue exclusion assays were performed to 
verify that a decrease in MTT conversion was due to a decrease in mitochondrial viability and 
not a decrease in total number of viable cells. Healthy cells with an intact cellular membrane will 
exclude the trypan blue dye, whereas dead cells will allow the dye to leak into the cytosol 
(Strober, 2015). Unlike the results obtained from the MTT assays, a decrease in cell viability was 
not apparent until HK-2 cells were exposed to at least 23 mg I/mL for 24 hr indicating that HK-2 
cells experience a statistically significant decrease in mitochondrial viability at a much lower 
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concentration and at an earlier time point when compared to the noticeable decrease in cell 
viability.  
The mitochondrial density of the kidney is relatively high compared to the rest of the 
body, second only in mitochondrial content and oxygen consumption to the heart (Bhargava & 
Schnellmann, 2017). The high mitochondrial content is due to the PT being responsible for the 
majority of transport within the kidney accounting for approximately 80% of all transport in the 
kidney (Zhuo & Li, 2013). Consequently, PT cells are fairly resistant to induction of pro-
apoptotic mechanisms via multiple mitochondrial protection pathways. PT cells experiencing 
intracellular stressors such as ischemia, reaction to xenobiotics, or inflammatory responses will 
undergo mitochondrial swelling, fission, and mitophagy in an attempt to withstand the insult 
(Tran & Parikh, 2014). HK-2 cells have similar activity to in situ PT cells, and this property 
could explain the discrepancy between the values obtained from the MTT and Trypan blue 
exclusion assays. 
The effects of RCM on mitochondrial function have been briefly studied in various 
models. Basal and uncoupled respiration measured using a Clark oxygen electrode were 
decreased in isolated PTs of New Zealand white rabbits after exposure to DA, ioxaglate, and 
iopamidol (Humes et al., 1987; Messana et al., 1990; Messana et al., 1988). It has also been 
shown that exposing HK-2 or LLC-PK1 cells to ioversol, iodixanol, or iohexol induces an 
increase in mitochondrial ROS production, as well as depolarization of mitochondrial 
membranes and stimulated the release of cytochrome c (Itoh et al., 2006; Lei et al., 2018). ATP 
production, and complex I and complex III activity were decreased in male Wistar albino rats in 
response to exposure to DA (Roza et al., 2011). The combination of these previous studies 
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indicates that there is an interaction between the mitochondria of PT cells and RCM; however, 
the source of this dysfunction is unclear.  
 This is the first study to conduct real-time screening to determine the effects of DA on the 
mitochondria of live, intact PT cells. Using the Seahorse XFe96 Analyzer, the effects of 
clinically relevant concentrations of DA on mitochondrial respiration, glycolysis, ATP 
production, and mitochondrial fuel utilization were determined in HK-2 cells. The cell mito 
stress test utilizes various compounds that have been validated to be useful in mitochondrial 
mechanistic studies (Eakins et al., 2016), such as the complex I and complex III inhibitors, 
rotenone and antimycin-A, which decrease oxygen consumption rate (OCR) and increase 
extracellular acidification rate (ECAR). The ATP synthase inhibitor oligomycin inhibit the 
electron transport chain downstream of the complexes I and III but do not affect spare respiratory 
capacity. Finally, the uncoupling agent, 2,4-dinitrophenol, increases both OCR and ECAR 
(Eakins et al., 2016). Exposure to DA induced statistically significant decreases in basal and 
maximal respiration, spare respiratory capacity, and ATP production within 8hr and continued to 
decrease these parameters through 24hr. Unfortunately, a global decrease in mitochondrial 
respiration does not necessarily predict the source of mitochondrial damage; for instance, the 
environmental agents 2,2’-methylenebis(4-chlorophenol) and pentachlorophenol were 
determined to be uncoupling agents because the compounds reversed oligomycin-induced 
inhibition of OCR (Datta et al., 2016). Previous work in our lab demonstrated that the HIV 
medication tenofovir may be an ATP synthase inhibitor due to its reduction of OCR and no 
effect on spare respiratory capacity in HK-2 cells. A study performed by Namba et al., 
determined that renal PTs experiencing metabolic acidosis in response to ammonium chloride 
showed similar results to HK-2 cells exposed to DA (Namba et al., 2014). The Namba group 
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concluded that the global decrease in respiration was due to an increase in mitophagy. The role 
of mitophagy in CI-AKI will be discussed in more depth later.  
 The glycolytic stress test determines the ability of a cell to utilize glycolysis as a source 
of ATP. The assay utilizes oligomycin to induce maximal glycolysis from which spare glycolytic 
capacity can be determined. Similar to mitochondrial respiration, comparing the compounds that 
are known to effect glycolysis can help predict the source of glycolytic damage. The pesticide 
maneb has been shown to decrease glycolysis and glycolytic reserve and increase OCR 
indicating that it differentially affects glycolysis and stimulates mitochondrial respiration 
(Anderson et al., 2018). Comparable to neuroblasts treated with maneb, HK-2 cells that are 
exposed to DA demonstrate decreases in both glycolysis and glycolytic reserve; however, this 
interpretation must be approached with caution. HK-2 cells depend on oxidative phosphorylation 
to a much greater extent than glycolysis as a source of energy production indicated by the very 
slight increase in ECAR following the addition of oligomycin, demonstrating that the spare 
glycolytic capacity of HK-2 is insignificant relative to oxidative phosphorylation. It is possible 
that the decrease in glycolysis is not due to damage to glycolytic machinery but, more likely, the 
disappearance of glycolytic substrates in response to the cells attempting to maintain ATP levels 
in the absence of functioning mitochondria.  
In order to verify that exposure to DA results in mitochondrial dysfunction and the 
reduction in glycolysis and glycolytic capacity is due to downstream effects, the real-time ATP 
rate assay was utilized. This assay uses oligomycin and rotenone/antimycin-A to determine total 
ATP, mitochondria-linked ATP, and glycolysis-linked ATP production. In response to exposure 
to DA, HK-2 cells experienced a statistically significant decrease in total ATP and mitochondrial 
ATP production. Conversely, a decrease in glycolytic ATP production was apparent, however, 
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not to a significant degree. These results indicate that exposure to DA preferentially affects the 
mitochondria compared to the glycolytic pathway and the decreases that are being observed are 
in response to energy demand or downstream effects of mitochondrial dysfunction.  
The ability of the mitochondria to utilize available fuel sources is vital for maintaining 
energy homeostasis. The mito fuel flex test determines the rate of oxidation of the three major 
mitochondrial fuels: pyruvate, glutamine, and long-chain fatty acids (LCFA). The assay 
determines the reliance on a particular pathway to maintain basal respiration, labeled fuel 
dependency, followed by the overall fuel capacity of each fuel source. The difference of these 
two values is the mitochondrial fuel flexibility, or the mitochondria’s ability to compensate for 
an inhibited pathway by using the other two pathways. UK5099 is an inhibitor of the 
mitochondrial pyruvate carrier (MPC) thereby blocking the glucose oxidation pathway and 
determining the dependency and flexibility of the mitochondria to utilize pyruvate produced via 
glycolysis. BPTES is an allosteric inhibitor of glutaminase (GLS1) resulting in inhibition of the 
glutamine oxidation pathway. GLS1 converts glutamine to glutamate which is then converted to 
α-ketoglutarate by glutamate dehydrogenase to be used in the citric acid cycle. Finally, etomoxir 
inhibits the LCFA transporter carnitine-palmitoyl transferase (CPT1A) which is critical for 
translocating LCFA from the cytosol into the mitochondrial matrix to be used for β-oxidation.  
In response to exposure to clinically relevant concentrations of DA, HK-2 cell’s ability to 
oxidize glucose, glutamine, and fatty acid is not affected to a significant degree. The flexibility 
of glucose and glutamine oxidation slightly increases in response to low and intermediate 
concentrations of DA; however, the increase also does not reach levels of significance. Aerobic 
respiration is the primary mechanism of ATP production in PT cells, with the central source of 
ATP coming from β-oxidation of LCFA, such as palmitate, which produce 3 fold the ATP per 
83 
molecule when compared to glucose oxidation (Bhargava & Schnellmann, 2017). According to 
the results of the mito fuel flex test (Figure 12), the oxygen consumption linked to each oxidative 
pathway within the mitochondria are approximately equivalent, indicating that HK-2 cells 
depend on each of the three pathways to a similar degree. It is also important to note that 
although we are seeing a decrease in every parameter of mitochondrial function as shown by the 
cell mito stress tests, the ability of the mitochondria to utilize the different fuel sources is not 
diminished. One would expect there to be a decrease in at least one oxidative pathway as a 
potential source of damage within the mitochondria; for example, if there was a decrease in 
glutamine oxidation in response to exposure to DA, it could be concluded that the diminishment 
of basal and maximal respiration seen in the cell mito stress tests could be attributed to 
dysfunction of electron transport chain machinery, glutamine conversion to α-ketoglutarate, or 
transport of glutamine into the mitochondria. The ability of the HK-2 cells to utilize LCFA is 
very slightly decreased in response to DA, and this could be explained by accumulation of LCFA 
as triglycerides within the cytosol. Triglycerides have been shown to accumulate within the 
cytosol of injured HK-2 cells, thereby decreasing the available LCFA to be utilized as a fuel 
source (Johnson, Stahl, & Zager, 2005). It is possible that the damage induced by DA at 8 hr is 
not severe enough to induce a decrease in the ability of the mitochondria to utilize each of the 
fuel sources, but we can conclude that the observed decrease in mitochondrial function is not due 
to diminishment of the ability of the mitochondria to utilize the three major fuel sources. 
A decrease in observable mitochondrial function in the absence of noticeable impairment 
of the oxidative machinery or transport of fuel may not indicate direct mitochondrial damage but 
could be caused by a decrease in the overall number of active mitochondria. Mitochondrial 
turnover, or mitophagy, is the main source of mitochondrial degeneration and has been 
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implicated in a number of diseases and conditions including CI-AKI (C. He & Klionsky, 2009; 
Lei et al., 2018; C. Zhao et al., 2017). The conversion of LC3BI, soluble form, to LC3BII, lipid 
form, is considered the major determining factor of mitophagy via the direct interaction of LC3 
adapters and mitochondrial substrates (Yoo & Jung, 2018). PTEN-induced putative kinase 1 
(PINK1) is continuously degraded by matrix processing peptidases within the mitochondria and 
subsequently cleaved by presenilin-associated rhomboid like (PARL) where it translocates to the 
cytosol and is entirely degraded (Matsuda et al., 2010). In the presence of mitochondrial 
membrane damage, the degradation of PINK1 is attenuated and it accumulates on the outer 
mitochondrial membrane (Park et al., 2015). The ubiquitin ligase Parkin is activated by 
phosphorylation on the mitochondrial membrane via interactions with PINK1, where it 
polyubiquinates substrates such as mitofusin I and II (MFS 1/II) (Nguyen, Padman, & Lazarou, 
2016; Tanaka et al., 2010). An LC3BI adapter molecule, such as sequestrome-1 (p62), is 
recruited to the polyubiquinated substrates where it is recognized by LC3BI and tagged for 
degradation via the autophagosome (Lazarou et al., 2015). Polyubiquinated substrates contain a 
LC3-interacting region (LIR) in which LC3BI recognizes, binds, and is converted into LC3BII. 
Therefore, a decrease in the ratio of LC3BI to LC3BII is an indicator of mitophagy.  
A study on the role of mitophagy in CI-AKI has already been reported using very high 
concentrations of RCM in an in vitro model. HK-2 cells exposed to 200 mg I/mL of iohexol and 
iodixanol expressed a statistically different increase in the ratio of LC3BII/LC3BI and an 
increase in p62 expression demonstrating an increase in mitophagy (Lei et al., 2018). In our 
study, clinically relevant concentrations of DA induced a significant increase in the ratio of 
LC3BII/LC3BI within 8 hr of exposure indicating that the diminishment of cellular respiration 
may not be due to mitochondrial damage but mitophagy. Our studies also suggest that mitophagy 
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may occur at levels that exist in the PT of a patient during development of CI-AKI. It has been 
shown that mitophagy may play a role in protecting PT cells from CI-AKI (Lei et al., 2018). 
Pretreatment of HK-2 cells with the inhibitor of autophagy, 3-methyladenine, resulted in more 
severe cellular toxicity induced by RCM (Lei et al., 2018). The increase of mitophagy seen in 
this study potentially explains why conversion of MTT is diminished within 2 hr of DA exposure 
but cell viability is not decreased until 24 hr.  
Disturbances in cellular homeostasis such as alterations in available ATP, redox status, 
and calcium regulation will result in misfolding or unfolding of proteins within the ER. 
Accumulation of misfolded or unfolded proteins within the ER activates the UPR and, if the 
instability is prolonged, will result in ER stress and apoptosis (Faitova, Krekac, Hrstka, & 
Vojtesek, 2006). The major purpose of the UPR is to reestablish the delicate balance between 
protein load and folding capacity of the ER. The ER is sensitive to homeostatic changes due to 
its dependency on a variety of fuel sources including saccharides for protein modifications, 
reducing equivalents for disulfide bond formation, and adequate ATP for calcium transport into 
and out of the ER (Bravo et al., 2013). Glucose-regulated protein 78 (GRP78) is an ER resident 
molecular chaperone that is considered the master regulator of UPR. Under normal physiological 
conditions, three ER transmembrane proteins, RNA-dependent protein kinase-like ER kinase 
(PERK), inositol-requiring ER-to-nucleus signal kinase 1 (IRE1), and activating transcription 
factor 6 (ATF6), are all kept inactive by interactions with GRP78 (Kim, Emi, Tanabe, & 
Murakami, 2006). Upon homeostatic disturbance, GRP78 dissociates from PERK, IRE1, and 
ATF6 where it binds to unfolded or misfolded protein leading to activation of the three proteins. 
PERK phosphorylates eukaryotic translation initiation factor 2α (eIF2α) resulting in attenuation 
of protein synthesis in an attempt to decrease ER protein load (Kim et al., 2006). Both IRE1 and 
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ATF6 activation leads to increased expression of ER chaperone genes and ER-associated 
degradation (ERAD) factors in order to fold or degrade unfolded and misfolded proteins (Kim et 
al., 2006; Yamamoto et al., 2007). However, if activation of the UPR regulators cannot restore 
homeostasis and activation of these regulators is extensively prolonged, PERK, IRE1, and ATF6 
signals converge to induce transcription of the central proapoptotic transcription factor in ER 
stress, C/EBP homologous protein (CHOP) (Oyadomari & Mori, 2004). The final step in ER 
stress is activation of the pro-apoptotic protease located on the outer surface of the ER, caspase 
12 (Rawlings & Salvesen, 2013). 
ER stress has been shown to play a role in a large number of pathophysiological disorders 
including the pathogenesis of ischemia/reperfusion injury and CI-AKI (X. Gao et al., 2012). The 
role of ER stress has been established in HK-2 and NRK-E52 cells exposed to HOCM and 
LOCM has previously been established. NRK-E52 cells exposed to 60 mg I/mL DA or 100 mg 
I/mL iopromide resulted in significant increases in GRP78, phosphorylated PERK, 
phosphorylated eIF2α, and CHOP expression (Wu et al., 2010; Y. Yang et al., 2014). HK-2 cells 
treated with 40 mg I/mL of DA induced statistically significant increases in GRP78, ATF4, 
CHOP, and caspase 12 mRNA levels (P. A. Peng et al., 2015). However, studies in our 
laboratory concluded that exposing HK-2 cells with clinically relevant concentrations of DA 
could not induce significant increases in GRP78 expression or the downstream pro-apoptotic 
protein CHOP. These findings indicate that activation of UPR or ER stress does not play a role in 
the decrease in cell viability in response to DA exposure. Interestingly, we found that exposure 
to 28 and 30 mg I/mL induced a significant increase in caspase 12 expression indicating 
activation of the ER transmembrane bound protease via another mechanism. Although the 
mechanism of activation of caspase 12 is not entirely understood, the role of cytokines and the 
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calcium dependent class of proteases called calpains may play a role (Berchtold, Prause, 
Storling, & Mandrup-Poulsen, 2016).  
The levels of calcium within physiological systems is tightly regulated. This regulation is 
due to the fact that calcium acts as an essential intracellular and extracellular messenger in 
numerous cellular events such as hormone secretion, muscle contraction, immune responses, 
activation of neuronal networks, and cell survival and death. Maintenance of extracellular 
calcium is held in a narrow range of 8.5-10.5 mg/dL and maintaining this range is important for 
intracellular calcium homeostasis. Approximately 70% of filtered calcium is reabsorbed in the 
PT via paracellular passive diffusion, intracellular leakage via claudin-2 located within the tight 
junctions of basolateral membranes (Jeon, 2008), and a small, but significant, amount of calcium 
is actively transported into the PT (Blaine, Chonchol, & Levi, 2015). Unfortunately, little is 
known about the mechanism of active transport within the PT, however, preliminary studies 
indicate that the membrane calcium channel transient receptor potential channel vanilloid 6 
(TRPV6) is distributed on the proximal tubule (J. B. Peng, 2019) potentially explaining the 
source of PT calcium transport.  
The central mechanism in maintaining intracellular calcium balance in basically all 
metazoan cells is store-operated calcium entry (SOCE). SOCE is based on the theory that: 1) 
cells possess multiple stores of intracellular calcium; 2) endogenous and exogenous agonists can 
induce release of calcium from these stores; 3) intracellular calcium mobilization will cause 
calcium efflux from the cell; 4) as time goes on, these stores need to be replenished (Hogan & 
Rao, 2015). Store-operated calcium channels (SOCCs) are activated in response to calcium 
release from the ER. G-protein coupled receptor or tyrosine kinase activation in response to 
binding of an endogenous or exogenous ligand result in activation of phospholipase C (PLC) and 
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formation of inositol-1,4,5-triphosphate (IP3). Binding of IP3 to IP3 receptors (IP3R) on the ER 
membrane induces calcium release into the cytosol (Prakriya & Lewis, 2015). Excess 
intracellular calcium is then effluxed from the cell via plasma membrane calcium ATPases 
(PMCAs) and Na+/Ca2+ exchangers (NCXs) (Guerini, 1998). As the ER luminal space becomes 
devoid of calcium, the primary ER luminal calcium sensor, stromal interaction molecule 1 
(STIM1), is activated and accumulates at ER-plasma membrane junctions (Roos et al., 2005). 
Accumulation of STIM1 subsequently activates the pore-forming subunit of SOCs, Orai1, and 
allows influx of calcium (Feske et al., 2006; Vig et al., 2006). As intracellular levels begin to 
rise, the sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCAs) actively pump 
calcium back into the ER restoring intracellular calcium to appropriate and defined 
concentrations (Mekahli et al., 2011). 
Aberrant function in intracellular calcium management has been indicated in a range of 
pathological conditions such as cardiovascular disease, diabetes mellitus, tumorigenesis, steatosis 
hepatitis, as well as ischemia reperfusion injury and CI-AKI. The relationship between calcium 
regulation, the ER, and the mitochondria is very complex and may play an important role in 
RCM-induced cytotoxicity. Soon after the characterization of carbohydrate metabolism and 
oxidative phosphorylation, it became clear that calcium had a special role in the mitochondrial 
physiology. Calcium can act as an uncoupler of oxidative phosphorylation because of the 
mitochondria’s ability to efficiently influx and accumulate calcium within the matrix at the 
expense of energy consumption (Deluca & Engstrom, 1961; Vasington & Murphy, 1962). 
Quickly thereafter, it was verified that: 1) calcium uptake into the mitochondria is dependent on 
an energy source such as ATP or other oxidizable substrates; 2) uptake is saturable indicating the 
existence of a carrier; 3) mitochondrial calcium influx is accompanied by stoichiometric 
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extrusion of H+ (Drago, Pizzo, & Pozzan, 2011). It was later discovered that two carriers were 
involved in mitochondrial calcium influx, the mitochondrial calcium uniporter (MCU) and the 
H+/Ca2+ antiporter (Brand, Chen, & Lehninger, 1976; Moyle & Mitchell, 1977). In healthy cells, 
the levels of calcium within the mitochondrial matrix are fairly low and range from 100 nM to 
1µM (Brinley, Tiffert, Scarpa, & Mullins, 1977; Ivannikov & Macleod, 2013; Somlyo, Bond, & 
Somlyo, 1985) and influx of calcium only becomes substantial when extramitochondrial calcium 
concentrations reach approximately 10 µM (Rizzuto & Pozzan, 2006). Conversely, it was 
discovered that even though the affinity of the MCU for calcium is very low (Kd = 20-30 µM), 
the mitochondria are capable of quick and substantial increases in matrix calcium levels, even at 
physiological increases in intracellular calcium (Rizzuto, Brini, Murgia, & Pozzan, 1993). 
Rizzuto et al. hypothesized that the discrepancy between low MCU calcium affinity and high 
efficiency of mitochondrial calcium influx was due to microheterogeneity of cytoplasmic 
calcium following stimulation. Rizzuto et al. suggested, and later confirmed by Giorgi et al., that 
the area between the calcium efflux proteins of the ER and MCU of the mitochondria can form a 
microdomain, later named the mitochondrial-associated membranes (MAMs) (Giorgi et al., 
2010). These microdomains of physiologically high concentrations of calcium were established 
to be approximately 10-20 µM (Csordas et al., 2010; Giacomello et al., 2010; Rizzuto et al., 
1998). These studies indicate that the mitochondria play an important role in intracellular 
calcium buffering at physiological and pathological concentrations.  
Calcium overload within the mitochondria is considered to be one of the main driving 
factors of cell death. Mitochondrial membrane permeability transition (mPT) is considered the 
initiator of the intrinsic apoptotic pathway and induction involves numerous factors. The only 
dogma pertaining to mPT is the accumulation of calcium within the mitochondrial matrix. 
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Inhibiting calcium influx into the matrix with ruthenium red completely abrogates mPT verifying 
the role of calcium in mPT (Haworth & Hunter, 1979). Accumulation of large amounts of 
calcium within the matrix leads to the opening of a large channel within the mitochondrial inner 
membrane referred to as the mitochondrial membrane permeability transition pore (mPTP). As 
the mPTP opens, proteins (< 1.5 kD) and solutes flood into the matrix resulting in uncoupling of 
oxidative phosphorylation, depletion of ATP, and permeabilization of the outer mitochondrial 
membrane (Hunter, Haworth, & Southard, 1976; Ott et al., 2002). Mitochondrial outer 
membrane permeability results in leakage of cytochrome c which binds to apoptotic protease 
activating factor (Apaf1) to form the apoptosome. The apoptosome continues to activate caspase 
9 and induce apoptosis (Morgan & Liu, 2010). 
The role of calcium homeostasis in the pathogenesis of CI-AKI has been established 
previously by various laboratories. The Yang group demonstrated that intracellular calcium 
overload may play a role in ROS overproduction, p38 MAPK activation, and apoptosis in CI-
AKI (D. Yang, Yang, Jia, & Ding, 2013; D. Yang, Yang, Jia, & Tan, 2013). Another study 
determined that exposure to 150 mg I/mL ioversol for 24 hr induced cytochrome c release and 
activation of caspase 3 in glomerular endothelial cells isolated from adult male Sprague-Dawley 
rats; however, pretreatment with the intracellular calcium chelator BAPTA-AM (5 µmol/L) 
completely attenuated the cytotoxicity (J. Zhao et al., 2009). Our studies confirm the Zhao group 
findings as pretreatment with BAPTA-AM completely alleviated DA-induced cytotoxicity in 
HK-2 cells as seen by MTT conversion. Whereas the Zhao study found that the extracellular 
calcium chelator EGTA had no effect on protecting glomerular endothelial cells from RCM-
induced cytotoxicity, pretreating HK-2 cells with EGTA did afford partial protection from DA-
induced cytotoxicity (Figure 24). Additionally, pretreatment of HK-2 cells with the IP3R 
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antagonist 2-APB also provided partial protection from diminished mitochondrial viability in 
response to DA exposure (Figure 24). Pretreatment with BAPTA-AM completely abrogated the 
conversion of LC3BI to LC3BII in response to DA (Figure 26), further suggesting that DA does 
cause intracellular calcium overload and mitophagy. It is clear from these results that calcium 
plays a major role in mitochondrial viability; however, the source of this calcium is still in 
question. It is likely that the DA-induced increase in intracellular calcium is caused by a 
combination of the release of calcium from the ER and calcium influx through SOCs due to the 
fact that both EGTA and 2-APB provided partial protection. 
Aside from inducing mPT, intracellular calcium overload can also induce cellular damage 
by other mechanisms. Prolonged surges in intracellular calcium has long been thought to activate 
a class of calcium-activated non-lysosomal cysteine proteases called calpains (Goll et al., 2003). 
It is hypothesized that during events of high intracellular calcium, inactive calpain translocates 
from the cytosol to the ER membrane and autocatalyzes resulting in the dissociation of the 30kD 
active subunit (K. Suzuki & Sorimachi, 1998). Calpain substrates do not have a specific 
recognizable amino acid sequence, therefore, a large variety of proteins are targets (Momeni, 
2011) including other pro-apoptotic enzymes like caspase 12. In fact, it has been previously 
shown that activation of caspase 12 requires calpain activation in vivo (Nakagawa & Yuan, 
2000). Pretreatment with calpain or calpain inhibitor-1 prior to exposure to RCM results in 
decreased antioxidant activity or reduced renal impairment, respectively, in rats (Baykara et al., 
2015; Briguori, Quintavalle, De Micco, & Condorelli, 2011; Chatterjee et al., 2001). Our studies 
have shown that HK-2 cells exposed to DA for 24 hr induced a two-fold increase in calpain 
activity and inhibiting calpain activity with calpeptin or chelating intracellular calcium with 
BAPTA-AM completely abrogated DA-induced calpain activation (Figure 24). To verify the role 
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of caspase 12 activation by calpain activity, HK-2 cells were pretreated with BAPTA-AM or the 
calpain inhibitor calpeptin prior to DA exposure. As a result, both BAPTA-AM and calpeptin 
inhibited the DA-induced increase in caspase 12 expression (Figure 28) indicating that caspase 
12 activation takes place in response to intracellular calcium overload and not to ER stress.  
Perhaps the most studied topic pertaining to the cytotoxicity of RCM is likely to be 
oxidative stress. As the production of reactive oxygen species (ROS) overwhelms the ability of a 
cell’s innate antioxidant systems to repress ROS reactivity, the ROS continuously and 
cumulatively damage the cell via interactions with cellular proteins, DNA, and other cellular 
structures (Gracy, Talent, Kong, & Conrad, 1999). Sources of ROS production vary but the most 
common endogenous sources are: 1) as byproducts of cellular metabolism through the electron 
transport chain (ETC), specifically complexes I and III; 2) one-electron reduction of O2 through 
enzymatic catalysis by NADPH oxidase (NOX) or xanthine oxidase (XO); 3) uncoupling of 
endothelial nitric oxide synthase (eNOS) (Mittal et al., 2014). The mitochondria ETC and NOX 
are the major sources of ROS generation within a cell (Di Meo, Reed, Venditti, & Victor, 2016; 
Phaniendra, Jestadi, & Periyasamy, 2015). In response to ROS production, cells have innate 
antioxidant systems to reduce oxidants to water and O2. The most common players in the 
endogenous antioxidant systems include: the enzymatic ROS scavengers superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione transferase, and the non-
enzymatic scavengers glutathione (GSH) (Birben et al., 2012). In the context of CI-AKI, a 
plethora of studies have been performed to confirm the formation of free radicals and oxidative 
stress as a result of exposure to RCM (Huang et al., 2016; Liss, Nygren, Erikson, & Ulfendahl, 
1998; Quintavalle et al., 2011; Rosenberger, Rosen, & Heyman, 2006); however, very few 
studies have addressed the source of ROS production. The purpose of this study was to verify 
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that clinically relevant concentrations do induce an increase in ROS and oxidative stress and 
identify the source of the excessive generation of ROS.  
Protein carbonylation is a generic term used to describe the irreversible interaction 
between reactive ketones and aldehydes formed in the presence of ROS and the side chains of 
proteins, specifically lysine, arginine, proline, and threonine (Y. J. Suzuki, Carini, & Butterfield, 
2010). This reactive carbonyl moiety will further impede biomolecule function, cause 
inflammation, cell toxicity, and induce apoptosis. Accumulation of proteins with carbonylated 
side chains indicates an increase in oxidative stress. Protein carbonyls can be recognized via 
derivatization with 2,4-dinitrophenylhydrazine (DNPH) to form hydrazones that can be detected 
using antibodies against DNPH-derivatized proteins (Levine, Williams, Stadtman, & Shacter, 
1994). A more specific biomarker for oxidative stress is the formation of protein-bound 
carbonyls induced by excessive lipid peroxidation. Most lipid peroxidation products are strong 
electrophiles and readily form Michael adducts with lysine, cysteine, and histidine side chains 
(Fedorova, Bollineni, & Hoffmann, 2014). The primary α,β-unsaturated hydroxalkenal formed 
during lipid peroxidation, 4-HNE, is one of the most commonly used biomarkers for oxidative 
stress and can easily be detected via immunoblotting.  
Our studies indicate that exposure to clinically relevant concentrations of DA induced 
oxidative stress in HK-2 cells as shown by an increase in protein carbonylation and 4-hydroxyl-
nonenal (4-HNE) protein adduct formation within 24 hr at 18 mg I/mL; however, no increase in 
oxidative stress was apparent within 8 hr. It is hypothesized that a major portion of direct 
cytotoxicity induced by RCM is caused by oxidative stress; our results indicate mitochondrial 
turnover at an earlier time point. Therefore, at clinically relevant concentrations, the increase in 
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oxidative stress is not the initial or sole cause of HK-2 cytotoxicity but is due to damage that is 
already taking place within the cell.  
The major source of endogenous ROS production is complex I and complex III of the 
electron transport chain within the mitochondria. Under normal physiological conditions, ROS 
generated in the mitochondria are involved in cellular crosstalk, signal integration of cell 
proliferation, differentiation, inflammation, repair, and apoptotic pathways (Li et al., 2017). 
However, in circumstances of perturbances in cellular homeostasis, such as alterations in 
NADH/NAD+ ratio, metabolic disturbances, or mitochondrial membrane damage, mitochondrial 
ROS generation surges (Li et al., 2013). Within the mitochondria of an affected cell, electrons 
leak from the intermembrane space at complex I and complex III where it interacts with O2 to 
yield superoxide (O2·-) radical. The mitochondria have an internal system to dispose of excess 
ROS that includes manganese superoxide dismutase (MnSOD) which dismutates O2·- into H2O2 
and glutathione peroxidase (GPx) which fully reduces H2O2 into water (Li et al., 2013). The 
mitochondria are at a disadvantage, however, due to the fact that it lacks catalase, a H2O2 
reducing enzyme, and depends on the reduction of glutathione disulfide to glutathione via 
glutathione reductase (GR) to reduce H2O2. As concentrations of the reducing equivalent 
NADPH decrease and glutathione disulfide increase, the antioxidant system within the 
mitochondria become overwhelmed (Sung et al., 2013). Once the antioxidant systems become 
overwhelmed, ROS interactions disrupt the mitochondrial membrane potential and permeability 
transition is eminent. As previously mentioned, mitochondrial outer membrane permeability 
results in leakage of cytochrome c which binds to apoptotic protease activating factor (Apaf1) to 
form the apoptosome. A study performed by Lei et al. indicated that exposure of HK-2 cells to 
200 mg I/mL iodixanol or iohexol induced statistically significant increases in mitochondrial 
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ROS production as shown by mitoSOX and TMRE staining (Lei et al., 2018). Our studies 
indicate that exposure of HK-2 cells to clinically relevant concentrations of DA induced the 
opposite effect. In fact, we noticed no change in 4-HNE protein adduct formation or protein 
carbonylation  within the mitochondria and the statistically significant increases in 4-HNE 
adduction and protein carbonylation takes place solely within the cytosol. To verify these 
findings, SOD activity assays were performed. We discovered that there was no change in 
MnSOD expression or activity, and the overall decrease in SOD activity was due, entirely, to a 
decrease in activity of the cytosolic SOD, Cu/ZnSOD.  
 The role of the cytokine tumor necrosis factor alpha (TNFα) was measured in response 
to DA exposure as a possible initiator of ROS generation. TNFα is an important cytokine in 
inflammation and is involved in many cellular responses including pro-survival and pro-
apoptotic pathways that have been shown to be affected in response to RCM exposure (Saritemur 
et al., 2015). TNFα has been shown to induce ROS production in a number of different pathways 
but most noticeably is through activation of NOX, specifically NOX4, in renal parenchymal cells 
(Sedeek, Nasrallah, Touyz, & Hebert, 2013). TNFα induces an increase in various NADPH 
oxidase components such as the NOX regulatory proteins p22phox and p47phox, NADPH 
oxidase organizer 1 (NOXO1) and NOX4 (De Keulenaer et al., 1998; Moe et al., 2006; Yoshida 
& Tsunawaki, 2008). A study performed by Jeong et al. demonstrated that exposing HK-2 cells 
to 150 mg I/mL iohexol induced statistically significant increases in NOX4 within 5 min; 
however, the group did not verify if the increase in NOX4 induced an increase in ROS at this 
time point (Jeong et al., 2018). In response to clinically relevant concentrations of DA, a 
statistically significant increase in TNFα in cell media and decrease in TNFα in cell lysate of 
HK-2 cells was apparent, indicating that DA does induce a mild inflammatory response in vitro. 
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However, NOX4 expression was unaffected in response to the increase in active TNFα. From 
these results, we can conclude that although TNFα is activated in response to DA exposure, the 
intracellular signaling is not strong enough to induce NOX4 transcription or activation. We can 
also conclude that TNFα and NOX4 are not playing a role in ROS generation or apoptosis in 
HK-2 cells.  
Excessive ROS generation induced by intracellular calcium dysregulation may play a role 
in CI-AKI. Intracellular calcium levels have been linked to ROS production in response to RCM 
(D. Yang, Yang, Jia, & Ding, 2013; D. Yang, Yang, Jia, & Tan, 2013). Calcium induced ROS 
production is linked to the interactions between mitochondrial calcium and increased ATP 
production and ROS generation, and calcium induced activation of NOX (Gorlach, Bertram, 
Hudecova, & Krizanova, 2015). However, our studies indicate that there is no change in NOX4 
activation and mitochondrial oxidative stress in response to DA exposure (Figure 20, Figure 21). 
Calcium may be inducing ROS production via calpain activation. In diabetic mouse and human 
umbilical vein endothelial cells, activation of calpain correlated with an increase in ROS 
production; whereas, transgenic mice over-expressing the endogenous calpain inhibitor 
calpastatin experienced significant reduction in ROS production (B. Chen et al., 2014). Our 
study indicates that pretreatment with BAPTA-AM or calpeptin completely abrogates 4-HNE 
adduct formation; however, protein carbonylation is not decreased to a significant degree. From 
these results, it can be concluded that the increase in lipid peroxidation that takes place in 
response to DA exposure is linked to calcium dysregulation and calpain activity.  
Apoptosis can be induced via two main pathways: the mitochondrial, or intrinsic, 
pathway; the ligand-mediated, or extrinsic, pathway. Both pathways involve two types of 
caspases: the initiator caspases (caspase 2, 4, 8, 9, 10, 11, and 12) and the effector caspases 
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(caspase 3, 6, 7). Activation of specific apoptotic pathways can be determined by measuring the 
appropriate caspase. Cleavage of caspase 9, for example, occurs in response to activation of the 
apoptosome and can be used as a determinant of initiation of the intrinsic apoptotic pathway. The 
apoptosome will then interact with and cleave executioner caspases such as caspase 3 resulting in 
programmed cell death. As previously mentioned, exposure to DA induces an increase in 
expression of the initiator caspase, caspase 12; however, caspase 12 activation occurs in the 
absence of initiation of the UPR or ER stress. Caspase 4 was measured as an indicator of the 
extrinsic apoptotic pathway. Caspase 4 is in response to binding of TNFα to the TNFα receptor 1 
(TNFR1), activation of the TNFα receptor-associated death domain (TRADD), and induction of 
extrinsic apoptosis. Caspase 4 has also been linked to ER stress linked apoptosis. HK-2 cells 
exposed to clinically relevant concentration of DA for 24 hr experience a statistically significant 
increase in TNFα activation but there was no noticeable change in caspase 4, indicating that ER 
stress and the extrinsic apoptotic pathway do not play roles in DA-induced apoptosis. Cleavage 
of caspase 3 was statistically increased in response to clinically relevant concentrations of DA, 
indicating that apoptosis is occurring within 24 hr and mitochondrial dysfunction may be the 
major contributing factor to the decrease in cell viability as seen by leakage of cytochrome c and 
the increase in mitophagy.   
CONCLUSION 
This study provides additional insight into the mechanisms of DA-induced renal 
epithelial cytotoxicity. DA induces a decrease in mitochondrial and cell viability within 2 hr and 
24 hr, respectively, as shown by MTT assays and trypan blue exclusion studies. Exposure to DA 
resulted in a decrease in basal and maximal respiration, spare respiratory capacity and ATP 
production within 8 hr as seen by changes in OCR and ECAR in Seahorse XFe assays; however, 
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the ability of the mitochondria to utilize the three major fuel sources (glucose, glutamine, and 
fatty acid oxidation) was unchanged, indicating that the decrease in mitochondrial respiration 
could be due to an increase in mitophagy. The ratio of LC3BII/I was increased after 8 hr 
exposure demonstrating that DA does, in fact, increase mitochondrial turnover. An increase in 
oxidative stress was apparent within the cytosol but not in the mitochondria as shown by protein 
carbonylation and 4-HNE protein adduct formation. Exposure to DA induced no change in 
MnSOD expression or activity confirming that the source of ROS overproduction is not within 
the mitochondria. Alternatively, the activity of Cu/ZnSOD was decreased in response to DA 
exposure. The role of TNFα in DA-induced cytotoxicity was evaluated by measuring NOX4 and 
caspase 4 expression but no change was detected. Therefore, the source of ROS overproduction 
remains elusive at this time. Caspase 3 and 12 activation was evident following a 24 hr exposure 
of HK-2 cells to clinically relevant concentrations of DA indicating that DA is inducing 
apoptosis. Caspase 12 expression is increased despite the fact that these concentrations of DA do 
not induce the UPR or ER stress as shown by GRP78 and CHOP expression. Pretreatment of 
HK-2 cells with calcium concentration modulators such as BAPTA-AM, EGTA, and 2-APB 
resulted in partial or complete protection from DA-induced mitochondrial toxicity demonstrating 
that calcium dysregulation plays a crucial role in CI-AKI. To determine if calpains play a role in 
caspase 12 activation, calpain activity assays were performed and determined that HK-2 cells 
exposed to 30 mg I/mL induces an increase in calpain activity. Pretreatment with BAPTA-AM 
completely abrogated the activation of calpain, caspase 12 activation, and the increase in 4-HNE 
adduct formation in response to DA exposure. Additional studies need to be conducted to 
determine the sources of ROS overproduction and calcium dysregulation, as well as the role of 
calcium in cellular homeostasis in response to RCM.   
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CHAPTER 4: SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS 
As the research for my dissertation comes to an end, my interest in CI-AKI and renal 
pathology has only been reinforced in the last five years. RCM are one of the most commonly 
administered drugs in a clinical setting and administration is only going to increase further in the 
future. As advances in human longevity are continuously made, the need for radiopaque 
diagnostic procedures will rise alongside, and cases of CI-AKI will increase as a result. 
Discovering the exact mechanisms of RCM-induced renal cytotoxicity are particularly relevant, 
as the overall number of patients with conditions causing advanced renal impairment such as 
diabetes mellitus, congestive heart failure, and advanced age are rising. The general goal of this 
project was to determine the mechanism of DA-induced proximal tubule cytotoxicity and to 
explore potential methods to alleviate this toxicity. My work provides insight into these 
mechanisms as well as evidence that pretreatment with calcium modulators mitigate this toxicity; 
this evidence warrants further study and may have potential clinical implications. 
CLINICALLY RELEVANT CONCENTRATIONS OF DA IS CYTOTOXIC TO HK-2 
CELLS 
The vast majority of studies pertaining to the discovery of the mechanisms of direct 
toxicity of RCM use concentrations that greatly exceed the concentrations within the kidney 
following RCM administration. It is not uncommon for studies to use concentrations that exceed 
twenty-fold the normal plasma levels of RCM following clinical administration in in vitro 
experiments. During a routine radiopaque imaging procedure, 45-150 mg I/mL RCM are 
administered intravenous for a 75 kg man and these concentrations can double as patients’ 
weight increase. It is at the clinician’s discretion to select the appropriate amount of RCM to use 
during these procedures, and the effective termination limit of a 76% DA preparation is 300mL 
(Skucas, 1989).  For a 75kg adult male, blood plasma levels will range from ~4 to 15 mg I/mL 
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but can reach as high as 30 mg I/mL as administered volumes increase (Lusic & Grinstaff, 2013). 
Mechanistic studies attempting to determine the mechanisms of cytotoxicity frequently expose in 
vitro models to concentrations of RCM well over 100 mg I/mL. In a study to determine the role 
of NOX4 and oxidative stress in response to RCM, HK-2 cells were exposed to 150 mg I/mL of 
iohexol (Jeong et al., 2018). The Yang group exposed NRK-52E cells to 150 mg I/mL of 
iopromide to determine the effects of RCM on the induction of ER stress (Y. Yang et al., 2014). 
Multiple studies attempting to verify the origin of cytotoxicity expose various models to 200 mg 
I/mL RCM (X. He et al., 2016; Netti et al., 2014; Quintavalle et al., 2011). It is possible that 
exposing cells to concentrations of RCM of this magnitude is inducing changes in cellular 
homeostasis that would not occur at clinically relevant concentrations of RCM. Therefore, the 
conclusions obtained from the results of these previous studies may be misleading.  
In this study, a wide range of clinically relevant DA concentrations (0, 2, 5, 10, 15, 18, 
23, 28, and 30 mg I/mL) were chosen to encompass what the kidney would experience following 
one of the plethora of imaging procedures used today. In response to clinically relevant 
concentrations of DA, mitochondrial and cell viability was diminished in HK-2 cells in a time-
dependent and concentration-dependent manner. Therefore, concentrations of DA that the 
normal, healthy kidney would experience in a clinical setting induce cytotoxicity, and this model 
can be used to examine the mechanisms of toxicity without the compounding in situ factors that 
are involved in CI-AKI.   
DA ALTERS MITOCHONDRIAL FUNCTION AND INDUCES MITOPHAGY IN HK-2 
CELLS 
Renal PT cells have high energy demands in order to maintain normal cellular function. 
To sustain appropriate levels of ATP, PT cells have the second highest mitochondrial density 
within the body (Bhargava & Schnellmann, 2017). A decline in basal respiration and maximal 
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respiration, and subsequent decrease in ATP production, in response to DA exposure would 
impair cellular homeostasis. Our studies determined that DA induces a global decrease in 
mitochondria-linked oxygen consumption resulting in diminished ATP production within 8 hr 
and 24 hr exposure at 23 and 15 mg I/mL, respectively (Figure 10, Chapter 3) as shown by 
Seahorse XFe cell mito stress tests. The Seahorse ATP-rate assay was utilized to determine if the 
decrease in ATP production was due partially to an interaction between DA and glycolysis. 
Exposure of HK-2 cells to DA does not induce a statistically significant change in ATP linked to 
glycolysis (Figure 11, Chapter 3) and the decrease in total ATP production was due to the 
decrease in mitochondria-linked ATP production (Figure 11, Chapter 3). In an effort to 
determine the source of mitochondrial dysfunction, the Seahorse mito fuel flex text was used. 
This assay measures mitochondrial fuel utilization and represents changes in cellular machinery. 
Exposure to DA did not affect the ability of HK-2 cells to utilize any of the three major fuel 
sources (Figure 12, Chapter 3) indicating that DA does not alter the function of glycolytic or 
mitochondrial energy utilization machinery.  
A global decrease in mitochondria-linked oxygen consumption in response to DA could 
indicate that DA is not directly damaging the mitochondria but inducing mitophagy via 
alternative mechanisms. One study utilizing Seahorse technology determined that an increase in 
mitophagy induced by metabolic acidosis in ammonium chloride treated transgenic mice 
containing green fluorescence protein tagged LC3 resulted in a global decrease in OCR in renal 
PTs (Namba et al., 2014). To determine if an increase in mitochondrial turnover is taking place, 
the expression of the biomarker for mitophagy, LC3B, was measured. HK-2 cells exposed to DA 
experienced a statistically significant increase in the ratio of LC3BII/I at 8 and 24 hr (Figure 13 
and 12, Chapter 3) indicating that DA induces an increase in mitophagy. The increase in 
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mitophagy, i.e. a decrease in the total number of viable mitochondria, could explain the decrease 
in the mitochondria-linked OCR and ATP production.  
DA CAUSES OXIDATIVE STRESS IN HK-2 CELLS  
In this study, we probed HK-2 cell whole cell lysate for the biomarkers of oxidative 
stress, protein carbonylation, and 4-HNE protein adduct formation. An imbalance between the 
production and removal of ROS in the favor of the former results in oxidative damage and stress 
(Birben et al., 2012). Various studies have indicated that exposure to RCM induces oxidative 
stress in vitro; however, this is the first study to show that clinically relevant blood plasma levels 
of DA cause oxidative stress in HK-2 cells. The concentrations in the higher range of what is 
considered clinically relevant induced a 50% increase in protein carbonylation and a subtle but 
significant increase in 4-HNE protein adduction formation within 24 hr (Figure 17 and 16, 
Chapter 3).  
We further investigated the oxidative damage following DA exposure in mitochondrial 
fractions. Previous studies have indicated that the mitochondria might be a potential target for 
DA-induced toxicity. Studies performed on PT isolated from New Zealand white rabbits exposed 
to approximately 160 mg I/mL DA or iopamidol demonstrated mitochondrial damage in the form 
of decreased basal respiration, uncoupled respiration, and ATP production (Humes et al., 1987; 
Messana et al., 1988). It is important to mention that although these studies expose PT cells to 
25mM DA or iopamidol, which is within the clinically relevant range, the cells were incubated 
with or without hypoxic conditions. Only the PT cells that encountered concomitant hypoxia 
experienced significantly greater metabolic alterations compared to control conditions, indicating 
that the HK-2 cell model is more susceptible to DA induced cytotoxicity than PT collected from 
New Zealand white rabbits. Our studies show that exposure to clinically relevant concentrations 
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of DA does not induce oxidative stress within the mitochondria. No change in protein 
carbonylation or 4-HNE protein adduct formation was evident within 24 hr (Figure 20, Chapter 
3).  
To verify these findings, total SOD, MnSOD, and Cu/ZnSOD activity assays were 
performed to determine the effect of DA exposure on HK-2 cell antioxidant systems. MnSOD is 
a nuclearly encoded antioxidant enzyme found specifically in the mitochondria responsible for 
the detoxification of O2•─. Multiple studies indicate that exposure to RCM decrease MnSOD 
activity in vivo and in vitro (Gong et al., 2016; Jeong et al., 2018; Tasanarong et al., 2014); 
however, the concentrations of RCM used in these studies were at least 150 mg I/mL, well above 
clinical relevance. Our studies indicate that exposure to DA results in a significant decrease in 
total SOD activity caused solely by diminished activity of the cytosolic SOD, Cu/ZnSOD. No 
change in activity was noticed in MnSOD (Figure 19, Chapter 3). To further verify that DA 
exposure had no effect on mitochondrial antioxidant capability, MnSOD expression was measure 
as well. As before, there was no noticeable change in MnSOD expression (Figure 19, Chapter 3). 
These results are contradictory to previously published data indicating that the initial source of 
oxidative stress is not within the mitochondria but via an alternative mechanism within the 
cytosol.  
TNFα is a pro-inflammatory cytokine that is expressed in PT epithelial cells and secreted 
in the inflammatory response to exogenous compounds (Gu et al., 2016). Binding of TNFα to 
TNFR1 can induce oxidative stress by downstream activation of NOXs and mitochondrial 
involvement (Morgan & Liu, 2010). TNFα levels have been seen to rise in response to various 
toxicants and ischemia alongside oxidative stress, activation of the inflammatory response, and 
apoptosis (Gong, Ivanov, Davidson, & Hei, 2015; Zager, Johnson, & Geballe, 2007). We 
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examined TNFα as a potential initiator of oxidative stress. Our studies showed that TNFα was 
released into the media and cell lysates showed diminished expression at 24 hr (Figure 21, 
Chapter 3). To verify the role of TNFα in the induction of oxidative stress and apoptosis, NOX4 
and caspase 4 expression were measured. Although there was a statistically significant increase 
in TNFα release into the media, no change in NOX4 or caspase 4 expression was apparent 
(Figure 21, Chapter 3) indicating that it is unlikely that TNFα plays a role in the observed 
oxidative stress or loss of cell viability noticed in response to DA exposure.  
DA INDUCES APOPTOSIS IN HK-2 CELLS 
Our study shows that a loss of cell viability occurs in HK-2 cells following a 24 hr 
exposure period to 23-30 mg I/mL DA. Cytochrome c leakage from the mitochondrial inner 
membrane space into the cytosol induces apoptosis by binding to the apoptotic protease 
activating factor 1 (Apaf-1) to form a complex that binds to and activates caspase 9 leading to 
caspase 3 activation (Jiang & Wang, 2000; X. Liu et al., 1996). Following a 24 hr exposure to 
clinically relevant concentrations of DA, there is an observable release of cytochrome c into the 
cytosol and a statistically significant increase in caspase 3 cleavage (Figure 22 and 21, Chapter 
3). Alternatively, DA exposure also induces an increase in expression of caspase 12 (Figure 23, 
Chapter 3). Although the mechanism of caspase 12 activation is not fully understood, interaction 
with calpains on the ER membrane surface (Tan et al., 2006) or via the IRE-xBP1 pathway 
(Faitova et al., 2006) have been hypothesized. Our results indicate that caspase 12 activation 
induced by exposure to DA occurs via calpain activity and in the absence of components of ER 
stress (Figure 15, 14, and 26, Chapter 3). These results indicate that clinically relevant 
concentrations of DA causes calcium dysregulation and mitochondrial dysfunction that initiates 
apoptosis.  
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DA CAUSES DYSREGULATION OF CALCIUM HOMEOSTASIS IN HK-2 CELLS  
Intracellular calcium concentrations are tightly regulated as calcium acts as an essential 
intracellular and extracellular messenger in numerous cellular events such as hormone secretion, 
muscle contraction, immune responses, activation of neuronal networks, and cell survival and 
death. A rise in intracellular calcium levels can induce a variety of cellular responses including 
induction of mitophagy, activation of a class of calcium-dependent cysteine proteases called 
calpains, or activation of mitochondrial membrane permeability transition, induction of the 
mitochondrial membrane transition pore, and induce cytochrome c release from the inner 
membrane space (Hunter et al., 1976; Ott et al., 2002).  
Our study demonstrates that exposure of HK-2 cells to DA causes dysregulation of 
intracellular calcium concentrations as shown by the results of the MTT assays with calcium 
chelators (Figure 24, Chapter 3). Pretreatment of cells with BAPTA-AM, EGTA, or 2-APB 
provides partial or total protection from DA-induced decreases in mitochondrial viability. The 
intracellular calcium chelator, BAPTA-AM, completely abrogated DA-induced mitochondrial 
damage indicating that DA causes dysregulation of intracellular calcium concentrations. To 
determine the source of excess intracellular calcium, the extracellular calcium chelator, EGTA, 
and the IP3R antagonist, 2-APB, were used. Both compounds provide partial protection 
indicating that calcium influx from outside the cell and calcium released from the ER both play a 
role in DA-induced calcium dysregulation. Prolonged increases in intracellular calcium activates 
calpains which are pro-apoptotic proteases. Calpain activity is increased two-fold in response to 
exposure to DA for 24 hr (Figure 25, Chapter 3) in HK-2 cells. To determine if calpain activity is 
linked to oxidative stress and caspase 12 activation, HK-2 cells were pretreated with BAPTA-
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AM or the calpain inhibitor, calpeptin. BAPTA-AM completely inhibited calpain activity, as 
well as abrogated the activation of caspase 12 in response to DA exposure.  
CONCLUSIONS 
Bridging the gap in knowledge pertaining to the mechanistic understanding of DA-
induced PT cytotoxicity is critical in determining clinical applications of preventing CI-AKI. We 
have determined that DA diminishes mitochondrial and cell viability with 2 and 24 hr, 
respectively. DA exposure induces aberrant regulation of intracellular calcium by intracellular 
and extracellular means. Calcium dysregulation within the PT induces an increase in mitophagy, 
cellular energy depletion, a loss in mitochondrial membrane integrity, and activation of calpains. 
The combination of calcium dysregulation and mitochondrial dysfunction results in a secondary 
response of lipid peroxidation and protein carbonylation. Loss of mitochondrial membrane 
integrity leads to cytochrome c leakage into the cytosol and activation of the executioner 
caspase, caspase 3. Calpain activation near the ER activates caspase 12 furthering the apoptotic 
cell signals in response to DA exposure (Chapter 3, Figure 29). Pretreatment of HK-2 cells with 
an intracellular or extracellular calcium chelator, or IP3R antagonist protects against DA-induced 
cytotoxicity within 24 hr. There are currently several intracellular calcium modulators available 
on the market and further studies are warranted to determine the role of these drugs in preventing 
CI-AKI.   
FUTURE DIRECTIONS 
 My study was the first to intensively investigate the mechanisms of cytotoxicity induced 
by clinically relevant concentrations of DA. Certain conclusions can be made from the results 
obtained from this study; however, many questions are still left unanswered. Several things still 
remain unknown such as the initial mechanisms of calcium dysregulation and ROS production. 
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The role of the IP3R-induced calcium efflux from the ER has been partially established in this 
study; however, there are various other calcium transport mechanisms. The sodium calcium 
exchanger (NCX), voltage-dependent anion channels (VDAC), and SERCA all transport calcium 
into and out of numerous compartments of the cell and could play a role in DA-induced 
cytotoxicity. More work needs to be done to determine if these transporters play a role in CI-
AKI. Although this study eliminates the mitochondria and NOX4 as potential sources of ROS 
overproduction, the initial source still eludes us. Additional research needs to be conducted to 
determine the role of calcium dysregulation and oxidative stress in regard to RCM exposure. 
Finally, calcium dysregulation, mitophagy, and ER stress are mechanisms that are co-dependent 
under normal circumstances. However, during DA-induced cytotoxicity, calcium dysregulation 
and mitochondrial turnover take place in the absence of ER stress. Further studies need to be 
performed to determine intracellular calcium concentrations within the different cellular 
compartments to verify the findings of this study. As previously mentioned, there are currently 
several intracellular calcium modulators such as calcium channel blockers. Several studies have 
shown various results pertaining to the use of calcium modulators and CI-AKI and more research 
is needed to determine the efficacy of calcium channel blockers (Beyazal, Caliskan, & Utac, 
2014; Oguzhan et al., 2013; Quintavalle et al., 2013). 
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Figure 29. Summary of DA-induced cytotoxicity. DA enters the proximal tubule cell via the 
OAT 1/3 transporters. Through an unknown mechanism, DA induces the release of calcium from 
the ER and influx via the store-operated calcium entry. As a result, calcium accumulates within 
the mitochondrial matrix where it induces the conversion of LC3BI to LC3BII triggering 
mitophagy. Prolonged periods of calcium accumulation within the mitochondria induces 
mitochondrial membrane transition and permeability, leakage of cytochrome c, activation of the 
intrinisic apoptotic pathway. Intracellular calcium overload in response to DA also induces 
calpain activity and activation of caspase 12, furthering the apoptotic cascade. Extracellular and 
intracellular modulation can attenuate DA-induced cytotoxicity.  
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APPENDIX B: LIST OF ABBREVIATIONS 
2-APB…2-aminoethoxydiphenyl borate 
4-HNE…4-hydroxynonenal 
8-OHdG…8-hydroxy-2`-deoxyguanosine 
ACEI…angiotensin-converting enzyme inhibitors 
Akt… protein kinase B 
Apaf1…apoptotic protease activating factor 1 
ARB…angiotensin-II receptor blockers 
ATCC…American Type Culture Collection 
ATF4…activating transcription factor 6 
ATF6…activating transcription factor 6 
BAPTA-AM…1, 2-bis (o-aminophenoxy) ethane-N,N,N’,N’-tetra-acetic acid  
BSA…bovine serum albumin 
CAT…catalase 
CHF…congestive heart failure 
CHOP…C/EBP homologous protein 
CI-AKI…contrast-induced acute kidney injury 
CPT1A…carnitine-palmitoyl transferase 
DA…diatrizoic acid 
DDTC… diethyldithiocarbamate  
DNPH…dinitrophenylhydrazine 
ECAR…extracellular acidification rate 
EGCG…epigallocatechin gallate 
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eGFR…estimated glomerular filtration rate 
EGTA…ethyleneglycol-bis(β-aminoethyl)-N,N,N’,N’-tetra-acetic acid 
eIF2α…eukaryotic translation initiation factor 2α 
eNOS…endothelial nitric oxide synthase 
ER…endoplasmic reticulum 
ERAD…endoplasmic reticulum-associated degradation 
ERK…extracellular signal-regulated kinase 
ETC…electron transport chain 
FCCP… carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
GFR…glomerular filtration rate 
GLS1… glutaminase 
GPx…glutathione peroxidase 
GR…glutathione reductase 
GRP78…glucose-regulated protein 78 
GSH…glutathione 
H2O2…hydrogen peroxide 
HEK-293…human embryonic kidney cells 
HK-2…human kidney 2 cells 
HOCM…high-osmolar contrast media 
IOCM…iso-osmolar contrast media 
IP3…inositol-1,4,5-triphosphate  
IP3R… inositol triphosphate receptor  
IRE1…inositol-requiring ER-to-nucleus signal kinase 1 
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JAK…Janus kinase 
JNK…c-Jun N-terminal kinase 
LC3B…Microtubule-associated proteins 1A/1B light chain 3B 
LCFA…long-chain fatty acids 
LIR…LC3-interacting region 
LLC-PK1…porcine kidney proximal tubule cells 
LOCM…low-osmolar contrast media 
MAM…mitochondrial-associated membranes 
MAPK…mitogen-activated protein kinase 
MCU…mitochondrial calcium uniporter 
MFS I/II…Mitofusin I and II 
MnSOD…manganese superoxide dismutase 
MPC…mitochondrial pyruvate carrier 
mPT…mitochondrial membrane permeability transition 
mPTP…mitochondrial membrane permeability transition pore 
MTT… 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NAC…N-acetylcysteine 
NCX…Sodium calcium exchanger 
NO…nitric oxide 
NOX…NADPH oxidase 
NOX4…NADPH oxidase 4 
NOXO1…NADPH oxidase organizer 1 
NRK52E…rat renal proximal tubule cells 
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NSAID…nonsteroidal anti-inflammatory drug 
O2·-…superoxide anion 
OAT…organic ion transporter 
OH-…hydroxyl radical 
OCR…oxygen consumption rate 
P62…sequestrome-1 
PARK2…Parkin 
PARL…presenilin-associated Rhomboid like 
PBS…phosphate buffered saline 
PBST…phosphate buffered saline plus Tween 20 
PCI…percutaneous coronary intervention 
PER…proton efflux rate 
PERK…RNA-dependent protein kinase-like ER kinase 
PI…propidium iodide 
PI3…phosphoinositide 3 
PLC…phospholipase C 
PMCA…plasma membrane calcium ATPase 
PINK1…PTEN-induced putative kinase 
PT…proximal tubule 
RAAS…renin-angiotensin-aldosterone system 
RCM…radiocontrast media 
ROCK…Rho-associated protein kinase 
ROS…reactive oxygen species 
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RSB…reducing sample buffer 
SERCA…sarco/endoplasmic reticulum calcium ATPase 
SOCE…store-operated calcium entry 
SOCC…store-operated calcium channel 
SOD…superoxide dismutase 
STAT…signal transducer and activator of transcription proteins 
STIM1…stromal interaction molecule 1 
SCr…serum creatinine 
TAL…thick ascending limb 
TBST…tris buffered saline plus Tween 20 
TMB…3,3t,5,5t-tetramethylbenzidine 
TNFα…tumor necrosis factor alpha 
TNFR1…TNFα receptor 1 
TRADD…TNFα receptor-associated death domain 
TRPV6…transient receptor potential cation channel subfamily V member 6 
UPR…unfolded protein response 
VDAC…voltage-dependent anion channel 
XO…xanthine oxidase 
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